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ABSTRACT

THE TANDEM ZINC-MEDIATED CHAIN EXTENSION-IODOMETHYLATION
REACTION AND ITS APPLICATIONS

By

QINGLIN PU
University of New Hampshire, September, 2007

A tandem zinc-mediated chain extension-iodomethylation reaction was developed
and used to generate various a-iodomethyl y-keto esters, amides and imides. The yields
for formation o f a-iodomethyl y-keto esters were higher than a-iodomethyl y-keto amides.
P-Keto amides with bulky substituents on the amide bond were not good substrates for
the zinc-mediated chain extension-iodomethylation reaction. Use o f a chiral P-keto imide
provided a facile means to effectively control the stereochemistry at the a-position o f the
extended chain with this methodology.
A palladium-catalyzed cross-coupling reaction was used to install different
functional groups at the a-carbon site o f an a-iodomethyl y-keto ester and imide.
Reactions between a-iodomethylated y-keto compounds and aromatic iodides or an
alkenyl bromide were performed successfully in modest yields. However, iodophenol and
1-fluoro-4-iodobenzene did not provide products when reacted with the a-iodomethylated
product under the same reaction conditions.

XV
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Other applications o f the a-iodomethyl y-keto ester were studied in an effort to
attach different alkyl groups to the a-position, including thiolation and nucleophilic
alkylation.
The a-substituted y-keto esters or imides can be designed to contain functionality
that mimics the side chain o f amino acids in a ketomethylene peptide isostere.

xvi
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CHAPTER I

INTRODUCTION

Chain Extension Chemistry
Chain extension methodology provides opportunities for organic chemists to
lengthen existing carbon chains to a desired chain length. The versatility o f chain
extension reactions have been shown in the preparation o f a variety o f building blocks for
bioorganic chemistry research. The generation o f 1,4-dicarbonyl compounds is o f great
interest in these research fields. Most common methods o f chain extension leading to the
1,4-dicarbonyl functionality involve the intermediacy o f a donor-acceptor cyclopropane,
which is defined by an electron donating group (alkoxyl or amino) and an electron
withdrawing group (ester, amide, phosphonate, imide, etc) being present on two adjacent
carbons o f a cyclopropane ring. A number o f different ways to form 1,4-dicarbonyl
compounds, especially y-keto esters via donor-acceptor cyclopropane, have been reported.
A brief review o f the various chain extension reactions is described below.
Bieraugel’s Method
Bieraugel and coworkers1 reported the first chain extension method used to convert
P-keto esters 1 to y-keto esters 5 in 1974. As a result o f the reaction between a P-keto
ester and a secondary amine, an enamine ester 2 was formed. When the Simmons- Smith
reagent was added to the enamine, 2-aminocyclopropane ester 3 was generated. This
donor-acceptor cyclopropane was believed to be the intermediate preceding formation o f
the

ring-opened

species

imine

4

in

this

reaction.

A

y-keto

1
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ester

was

produced after hydrolysis o f the imine intermediate (Scheme 1). Although low yields in
the conversion o f various P-keto esters led to limited applications for this method,
Bieraugel’s strategy was the first method reported to pursue chain extension reaction with
a donor-acceptor cyclopropane.

nhr2 .

R

nr2

OR

o

n r 2.

o

Zn-Cu, Etl ^
OR

"OR

R

CH2 I2

H
3

O

%R2
OR

R'

O

c NH4CI

h 20

R-

R.

.OR'
O

Scheme 1. Bieraugel’s Method for Formation o f y-Keto Esters 5

Saigo’s Method
Saigo and coworkers modified Bieraugel’s method through the formation o f a
trimethylsilyl (TMS) enol ether 6, and applied this strategy to a series o f p-keto esters and
P-diketones (Scheme 2).3 When the TMS enol ether was trapped with the SimmonsSmith reagent, two different TMS protected cyclopropyl alcohol intermediates 8 and 10
appeared to have been formed in the process o f the reaction. Multiple additions o f the
methylene groups took place and the formation o f an unexpected mixture o f carboxylic
acids 11 and 12 were isolated after saponification. No unsubstituted y-keto ester was
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formed in this multi-step process, most likely due to migratory aptitude o f the silicon.

O

™xi
R

OR

OTMS

OTMS

Zn/Cu

R -^ ^ ^ O R

c h 2 i2

8

TMSQ
TMSO

a)KOH/CH3OH

Zn/Cu
OR
c h 2 i2

R

b)H30

OR

R
O

O
10

o

o

11

12

Scheme 2. Saigo’s Method for Formation o f y-Keto Acids 11 and 12

Dowd’s Method
Dowd and coworkers developed a different strategy for the formation o f y-keto
esters from substituted P-keto esters in which a free radical-mediated ring expansion
reaction was involved (Scheme 3).4 The substituted P-keto ester starting material 13,
which was prepared by addition o f an a-substituted P-keto ester with methylene
dibromide, was treated with tri-n-butyltin hydride in the presence o f AIBN to generate a
radical intermediate 14. This radical species was proposed to attack the adjacent carbonyl

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

group to form a donor-acceptor cyclopropanoxy radical 15, followed by fragmentation to
generate an ester stabilized radical 16. Capture o f a hydrogen atom from tri-n-butyltin
hydride completed the formation o f the product and continued the radical chain reaction.
Dowd’s method has been shown to provide access to a variety o f chain extended or
ring-expanded products, especially for the formation o f five to eight-membered rings.4
The targeted compound was always an a-substituted y-keto ester, for this methodology
was not applicable to a-unsubstituted P-keto esters. The most likely explanation is that
competing E2 reactions would take place through the removal o f an acidic proton on the
a-position o f 13 (R ’= H) during the alkylation o f starting P-keto ester.

O

O
BU3 S11H

J R

»

AIBN

1- 0 0
r 0\ 0 1
i I
>r/JL
^OR"
R'/^ f VOR" ---- ►
./ R'
V
15

Br
13

14

O

R'

r
OR"

O

R’

BU3S11H

OR"

R
O

O
17

16

Scheme 3. Dowd’s Method for Formation o f y-Keto Esters 17

4
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Reissig’s Method
Reissig’s research group developed a [2+l]-cycloaddition strategy in which a
carbenoid derived from methyl diazoacetate in the presence o f copper (II) acetylacetonate
was trapped with a silyl enol ether 18 to generate a cyclopropane intermediate 19.5
Fluoride promoted the fragmentation o f the cyclopropane ring and offered the y-keto
ester 5. Although a different starting material, which was derived from a ketone species
rather than P-keto ester, was used in this method, the common donor-acceptor
cyclopropane was involved in the formation o f the y-keto ester. This was a
complementary chain extension reaction to previous methods.

O
H

TMSO

F or H

/
H

18

H

OR'

Cu (acac )2

,OR'

R
5

O

19
1) A= C 0 2 R', B=H
2) A= H, B = C 0 2 R'

Scheme 4. Reissig’s Method for Formation of y-Keto Ester 5

Zinc-carbenoid-mediated Chain Extension
A zinc-mediated chain extension methodology has been developed by Zercher’s
research group. The chain extension reaction utilizes Furukawa-modified SimmonsSmith cyclopropanation conditions for the preparation o f y-keto esters from aunsubstituted p-keto esters.6 The proposed mechanism o f this zinc-mediated chain

5
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extension is believed to involve formation o f a donor-acceptor cyclopropane (Scheme 5).
Deprotonation

o f the

p-keto

ester

by

diethyl

zinc

or

the

zinc

carbenoid

(ethyl(iodomethyl)zinc) derived from Et2 Zn and CH 2 I2 results in the formation o f the zinc
enolate 20, which has been confirmed as an intermediate by NMR studies and production
o f ethane gas as a byproduct o f enolate formation.7 Direct alkylation o f the zinc enolate
with the carbenoid EtZnCfEI could provide the zinc intermediate 21. The cyclopropyl
alkoxide intermediate 22 is assumed to be generated through an intramolecular
cyclization, but no direct evidence supports the presence o f this cyclopropane
intermediate, possibly due to its rapid fragmentation to an oligomeric zinc species 23,
which bears structural and reactivity similarity to a Reformatsky intermediate. Quenching
with an acid, such as aqueous ammonium chloride solution produced an a-unsubstituted
y-keto ester 5. This one-pot method is more efficient and is easier to perform than the
previously reported chain extension methods, which usually involved multi-step
sequences. The efficiency o f the zinc-mediated chain extension reaction is unaffected by
the presence o f olefin functionality.6

6
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ZnX

O

O

O

O
OR’

R'

'OR

CH2 C1;

OR'
L XZn'

1

21

20

ZnX

OZnX

Zn

OR’

OR’
OR’
24

23

22

O
OR'

O

Scheme 5. Mechanism o f the Zinc-mediated Chain Extension Reaction

This zinc-mediated chain extension reaction has been successfully applied to a
variety o f functionalities such as P-keto amides 25, phosphonates 278 and imides 29
(Scheme 6).7These substrates work with the zinc carbenoid in a similar pattern compared
to P-keto esters. Although the zinc carbenoid method works inefficiently with asubstituted P-keto dicarbonyl substrates, tandem zinc-mediated chain extension reactions
provide attractive approaches to target the desired a-substituted y-keto compounds.

7
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a) Et2Zn, CH2I2
b) NH4CI

25

O

26

O

O

.0

a) Et2 Zn, CH2 I2

P~ ° '

O-

b) NH 4 CI

O

0

-

28

27

0

'

0

O

0
a) Et2Zn, CH2I2>
b) NH4CI

O
29

O

30

Scheme 6. Chain Extension o f P-Keto Amides, Phosphonates and Imides

Recently Xue and his coworkers reported a modified zinc-mediated chain extension
reaction for the generation o f a-unsubstituted 1,4-diketones 32 from a-unsubstituted 1,3diketones 31 by using a different organozinc carbenoid (CFsCC^ZnCEkl).9 This
carbenoid was prepared by treatment o f the original carbenoid (EtZnCFkl) with
trifluoroacetic acid (Scheme 7). The proposed mechanism by Xue and coworkers, which
still involved in generation o f the cyclopropane intermediate, was based on analogy to
Zercher’s proposed mechanism. Both aromatic and aliphatic 1,3-diketones were
employed to give corresponding 1,4-diketone products in moderate yields. No desired
compounds were observed in the reactions o f a-substituted P-diketones and excess
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amount o f zinc carbenoid resulted in formation o f 1,2-disubstituted cyclopropyl alcohols.
This carbenoid has also been applied to the ring expansion of P-keto lactones.98

a)CF3 C 0 2 ZnCH2I

31

32

Scheme 7. X ue’s Chain Extension Reaction for the Formation o f 1,4-Diketones 32

Tandem Chain Extension Methylation Reaction
Based upon the practical limitation o f zinc-mediated chain extension in the direct
formation of a-substituted y-keto esters and amides from a-substituted P-keto esters,
Zercher and Hilgenkamp reported a variation on the chain extension reaction that
provided a useful solution to this limitation.7,10 This approach was utilized to produce amethylated y-keto esters and amides in modest yields. In order to facilitate methylation,
trimethylsilylchloride (TMSC1) was added prior to quenching the reaction mixture
(Scheme 8). The trimethysilyl group appeared to aid fragmentation o f the proposed
dimeric species and formation o f an activated intermediate, which could be TMS-ketene
acetal species 33 or trimethylsilyloxycyclopropane 34. Either intermediate could act as a
nucleophile and attack the electrophilic carbenoid, which was present in excess in the
reaction, and provide a zinc homoenolate intermediate 35. When quenched with an acid,
the a-methyl y-keto esters 36 were obtained.

9
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R

R

R

R'

OTMS

OR'
23

34

33
ZnX

O
EtZnCH2I

O
H®

OR'

R

OR'

R
O

O
36

35

Scheme 8. Proposed Mechanism o f Chain Extension Methylation Reaction

In an effort to test the efficiency o f the tandem chain extension a-methylation
reaction, several P-keto esters or amides were exposed to the reaction conditions. The
desired a-methylated y-keto esters and tertiary amides were obtained in yields ranging
from 57% to 73% after column chromatography. The data suggests that the methylation
reaction was not hindered by the existence o f a bulky substituent or aromatic ring on the
ester or amide functionality.

Table 1. Preparation o f a-Methyl y-Keto Esters
Entry

R

R

Yield (%)

1

ch3

ch3

63

2

ch3

tBu *

73

3

ch3

CH2Ph

57

4

c 6h 5

Et

70

10
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In contrast to the good yields o f a-methylated y-keto esters, secondary P-keto
amides, such as A-cyclohexyl 3-oxo-butanamide 37, provided low yields o f the
corresponding a-methylated y-keto amides 38 (Scheme 9). a-Unsubstituted y-keto
amides 39 were the major products o f the reaction. A proposed explanation for these
results, which was supported by deuterium labeling studies, is that the secondary P-keto
amide proton partially quenches the dimeric zinc species before its conversion to TMSketene acetal species 33 or trimethylsilyloxycyclopropane 34.

O

O
b) cat TMSC1

38 (14%)

37

39 (48%)

Scheme 9. Synthesis o f a Secondary a-Methyl y-Keto Amide 39

Tandem chemistry has been explored to expand the applications o f the zincmediated chain extension reactions. For example, trapping the intermediate zinc enolate
24 with a halogen as an electrophile, followed by elimination with an amine base,
provides an a,P-unsaturated y-keto ester 41.11 Chain extension-aldol reactions, which
involve the reaction between the zinc enolate 24 and various aldehydes provide the
predominant syn-aldol products 40, with stereoselectivity much greater than in the typical

11
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Reformatsky reaction (Scheme 10).

12

o

.RV

.OH
OR'

R

O

ZnX
40
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AA
A
24

OR'

R-

O
41

Scheme 10. Applications o f the Chain Extension Reaction

Introduction to Peptide Isosteric Replacements
Over the past two decades, the utility o f 1,4-dicarbonyl compounds as components
o f novel bioactive agents such as peptide inhibitors has been explored.13, 14 Peptide
mimetics can be designed to mimic or block the bioactivity o f natural peptides or
enzymes. For example, peptide isosteres have been widely used as inhibitors o f aspartic
acid proteases (such as renin15), cysteine proteases 16and serine proteases.17 The cleavage
of a normal peptide bond is described briefly in Scheme 11.

ID

Peptide isosteres are

generated when the amide bonds o f a peptide are replaced by other functional groups o f
similar size that are hydrolytically stable. In these cases peptide isosteres are capable o f
maintaining similar binding properties as the natural peptide, but are not easily
enzymatically degraded.19 Therefore, design and synthesis o f peptidomimetics are crucial
components o f bioorganic and medicinal chemistry research. A number o f functional
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groups have been used to mimic the structure o f peptide bonds, including ketomethylene
46,20 hydroxyethylene 47,21 alkenes 4822 and difluoroketomethylene groups 4923 (Figure

1).

hydrolysis
H 2 0 , enzyme

O
further cleavage

7----- :-----

OH

►

+

h 2n

►

o

r

44

2

45

Scheme 11. Hydrolysis o f a Peptide Chain
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48

49

Figure 1. Isosteric Replacements o f Peptide Amino Bonds

Previous Methods for Preparing Ketomethylene Isosteres
The ketomethylene replacement has proven to be effective in inhibition o f a variety
o f enzymatic systems, such as HIV protease,24 arginine aminopeptidases, 25 angiotensinconverting enzyme (ACE),26 human rhino virus (HRV) 3C protease,27 and retroviral
protease.

This type o f isostere has been incorporated in synthetic drugs (i.e.

Ruprintrivir),14 as well as being observed as a key functionality in naturally-ocurring
protease inhibitors (i.e. Arphamenines).250 Many approaches to the generation o f
ketomethylene isosteres have been investigated, and a brief review on this area is
provided below.
One common method reported for the formation o f ketomethylene isosteres
involves reactions o f a Grignard reagent 51 (Scheme 12).25a The Grignard reagent
derived from a chiral propyl bromide 50 was reacted with an TV-protected protected amino
acid derivative, normally amino aldehyde 52, to generate intermediate alcohol 53.
Protection o f the secondary hydroxyl group by acetylation was followed by removal o f

14
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the benzyl ether by hydrogenolysis, which provided a primary alcohol. This alcohol was
oxidized to the corresponding acid 55 using ruthenium chloride and coupled with other
amino acid derivatives. Cleavage o f the acetyl group and further oxidation provided the
protected ketomethylene-containing isostere 57. However, the oxidation process was
troublesome and racemization often occurred due to the presence o f amino aldehydes.

R'

N
Mg

"OBn

52

0

» PG.

OBn

THF

R

OH
53

50

A c20

NMM

i•

coupling w ith

,

PG^

I,

1) H2 /Pd/C
*

amino acids
OAc

i
R

0H

______

PG.

OBn

2) RuCl3 /NaI0 4
OAc

55

Rh

54

1) MeOH, K2 C 0 3

----------------------- ►
OAc

R

PG

2) PDC, DMF/HOAc

R

56

Scheme 12. Synthesis o f Ketomethylene Isosteres Using Grignard Reagents

Hoffman

and

his

coworkers

developed

another

synthetic

approach

to

ketomethylene isosteres. The key step in this approach was the formation o f a y-keto ester
through direct alkylation o f a P-keto ester.29 The p-keto ester 59 was prepared by treating
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the lithium enolate o f /-butyl acetate with an activated derivative o f amino acid 58.
Addition o f sodium hydride to the P-keto ester resulted in the formation o f the enolate,
which was exposed to ethyl bromoacetate. Alkylation o f the P-keto ester provided the asubstituted y-keto ester. Cleavage o f the /-butyl ester and decarboxylation by treatment
with trifluoroacetic acid (TFA) provided the y-keto ester 60. Hydrolysis with lithium
hydroxide and coupling with proline methyl ester gave the ketomethylene-containing
peptide chain 61 (Scheme 13).

a) CDI

Cbz,

OH

a) NaH

■*■ Cbz.

b) BrCH2COOEt
LiO'

c) TFA

OtBu

58

59

O

R
Cbz,

XN
H

OEt
O

60

O

R
at LiOH

Cbz.

b) HOBT, EDC1
P

COOMe
N
H

O

MeOOC
61

Scheme 13. Synthesis o f Ketomethylene Isosteres through Alkylation o f P-Keto Esters

Another similar strategy was illustrated by the same authors using scalemic
alkylating agents 2-triflyloxy esters 63, which allowed the incorporation o f the asubstitution.30 Since tert-butyl P-keto esters could be deprotected and decarboxylated
easily under acidic conditions, the /-butyl esters were used in alkylation reactions to
improve overall yields in this modified method. Alkylation o f /-butyl P-keto esters 62
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with 2-triflyloxy esters 63 followed by treatment o f the crude alkylation product by TFA,
followed by LiOH gave y-keto acids 66. The resulting y-keto acids were coupled to chiral
a-methylbenzylamine 67 to provide peptide isosteres 68 (Scheme 14). This chiral
alkylation methodology offered high enantioselectivities for preparation o f a-alkylated yketo esters and acids, however, the deficiency o f the suitable chiral alkylating reagents
limits the application o f this method.
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O

R2

R2

? B u O -^ 0

63

62

O

R?

R

HOBT, EDC1

N.

^C6H5

c o 2h

H2N

66

Scheme 14. Synthesis o f Ketomethylene Isosteres Using Chiral Alkylating Reagents

Another synthetic approach to ketomethylene isosteres, which was reported by
•> |

Lygo and Rudd in 1995, involved the use o f a P-keto sulfone intermediate.

The Boc-

protected amino acid ester derivative 69 was reacted with a dianion derived from
methylphenylsulfone to generate the desired sulfone 70, which could undergo the
reaction with bromoacetate derivatives 71 to provide P-keto sulfone intermediate 72.
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Direct reduction using samarium iodide (Sink) in a mixture o f THF and MeOH afforded
the ketomethylene tripeptide isosteres 73 (Scheme 15). Although this short route allowed
for formation o f peptide isosteres that were related to HIV protease inhibitors,
epimerization was still observed during the base-catalyzed coupling reaction.

B -N ^ o M e

B o c H N ^

THF

R]
69

OMe

70
71

A

BocHN
R,

0
S 0 2PhO

H

SmI2

R ™ BK
H
N
^ r N
Y 0M
'
—'

►Ducni'i^
-OH

R2

=

R

72

a

A

73

Scheme 15. Synthesis o f Ketomethylene Isosteres through a P-Keto Sulfone

As described above, generation o f ketomethylene-containing peptide mimics often
requires lengthy and demanding synthetic sequences. Control o f stereochemistry o f the acarbon side chain has also been shown to be a challenge in most o f these synthetic
approaches. Recently Zercher and coworkers demonstrated a simple and efficient zinc
carbenoid-mediated method that facilitates the conversion o f P-keto esters to y-keto esters
and allows for the potential incorporation o f a-side chain functionality.32 JV-Protected
amino acids 74 were subjected to a neutral C-acylation reaction through intermediate acyl
imidazoles to provide the corresponding P-keto esters 75. The target y-keto esters 76 were
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formed in good yields via a zinc-mediated chain extension reaction. Cleavage o f the
benzyl ester by hydrogenolysis, followed by EDC coupling with the methyl ester o f
phenylalanine yielded the tripeptide mimic 77 (Scheme 16) as a single diastereomer. No
epimerization of amino acid stereocenters was observed by chiral HPLC study.
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b) Mg( 0 2 CCH 2 C0 2 Bn ) 2

CH 3
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OBn
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H
a) H2, Pd/C
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'
-*■ Boc
b) EDC, HOBT
Bn

OCH3

OCH,

H,N

77

O

Scheme 16. Synthesis o f Ketomethylene-containing Tripeptide Isosteres through Zincmediated Chain Extension Reaction

Application o f tandem reaction processes, including tandem chain extension-aldol
and chain extension-methylation reactions, has provided access to a-substituted
ketomethylene isosteres. Through appropriate selection o f starting materials and
subsequent manipulation o f the tandem reaction products, a-side chains that mimic
natural amino acid side chains have been produced (Scheme 17).
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Scheme 17. Preparation o f a a-Substituted y-Keto Imide 80 through Tandem Chain
Extension-aldol Reaction

Although many approaches have been used for the synthesis o f ketomethylene
isosteric replacements, satisfactory results have not been obtained in all cases. The zinc
carbenoid-mediated chain extension reaction provides an opportunity to synthesize
ketomethylene isosteres via a novel synthetic route; however, efficient mimicry o f the
peptide backbone requires a substituent, normally an alkyl group, at the a-carbon site.
Furthermore, control o f this a-stereocenter is essential to the efficient formation o f the
isostere. The diversity o f side chains required in ketomethylene isosteres suggests that a
variety o f routes are required for the incorporation o f the side chain. Development o f an
efficient methodology for the preparation o f ketomethylene isosteres o f peptide bonds
that facilitates the stereocontrolled incorporation o f diverse side-chain functionality has
become an urgent priority in this research area.
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CHAPTER II

RESULTS AND DISCUSSION

Zinc-mediated Chain Extension-iodomethylation
The utility o f the zinc-mediated chain extension reaction has expanded recently to
the preparation o f ketomethylene-containing peptide isosteric replacements.

^9

As

expressed in chapter I, the zinc-mediated chain extension methylation reaction provides
the ability to incorporate an a-methyl substituent in y-keto esters and amides through
treatment o f the intermediate zinc enolate equivalent with excess carbenoid and catalytic
TMS-C1.7’10 Since information gained from previous experimental data indicates that
nucleophilic character is present in the zinc homoenolate, treatment with iodine provides
the opportunity to generate a-iodomethyl y-keto esters 81 (or amides). The opportunity to
perform subsequent chemistry leading to the formation of various a-substituted y-keto
esters (amides) is presented due to reactivity o f the iodomethyl group. The zinc-mediated
chain extension-iodomethylation reaction derived from chain extension methylation
reaction is shown in Scheme 18.

ZnX
Zn

TMS-C1

OR'

OR'

R

OR'

O
35

Scheme 18. Zinc-mediated Chain Extension-iodomethylation Reaction
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Synthesis of a-Iodomethyl y-Keto Esters
The chain extension-iodomethylation reaction was first conducted on P-keto esters.
Three representative P-keto esters (methyl pivaloylacetate, benzyl acetoacetate, and tbutyl acetoacetate) were chosen as substrates for the chain extension-iodomethylation
reaction. Based upon previous optimization o f the conditions for the chain extension
methylation reaction investigated by Hilgenkamp, the iodomethylation reaction was
performed on the substrates using a similar procedure.10 Exposing P-keto esters to five
equivalents o f carbenoid derived from the reaction system, followed by addition o f
catalytic trimethylsilylchloride (0.2 equivalents) and excess iodine, provided the desired
a-iodomethyl y-keto esters in
chromatography.

The

results

satisfactory yields after purification by column
showed

that

the

efficiency

o f chain

extension-

iodomethylation is not hindered by the presence o f a bulky or aromatic group on the ester
oxygen, which is consistent with the results found in the chain extension methylation
reaction.

Table 2. Preparation o f a-Iodomethyl y-Keto Esters
Entry

R

R’

Product
(Yield)

1

f-Butyl

ch3

82(58% )

2

ch3

f-Butyl

83(62% )

3

ch3

CH2Ph

84 (60%)

From a !H NMR investigation o f the crude reaction mixtures, five compounds were
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observed in the reaction o f methyl pivaloylacetate. Those compounds were identified as
the targeted a-iodomethyl y-keto ester 82, (3-iodomethyl y-keto ester 85, a-iodo y-keto
ester 86, a-methyl y-keto ester 87 and simple chain-extended product y-keto ester 88. The
small amount o f compound 86 was believed to result from

85

87

86

88

Figure 2. Products in the Crude Mixture o f Iodomethylation Reaction on Methyl
Pivaloylacetate

the chain extended y-keto ester by treatment with iodine prior to quench with saturated
ammonium chloride solution. This result was probably due to the inefficiency o f the
chain extension methylation reaction. An easy way to enhance the methylation was to
increase the reaction time after addition o f TMSC1 to the reaction mixture from 30 min to
60 min. The compounds 86 and 88 were not observed in the ’H NMR spectrum o f the
crude mixture after this change was made. The a-methyl y-keto ester 87 could be
eliminated from the reaction mixture by increasing the equivalents o f iodine from 2.0 to
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5.0 and extending the iodonation time to 10 min after the appearance o f a constant purple
color o f reaction mixture.
The most interesting byproduct, observed in preparation o f the a-iodomethyl y-keto
ester o f methyl pivaloylacetate, was the P-iodomethyl y-keto ester 85. The compound was
hard to separate from the a-iodomethyl y-keto ester 82 by column chromatography. When
comparing NMR spectra o f compounds 82 and 85, a minor difference was the chemical
shift o f the methine proton adjacent to the iodomethyl group. The proton o f 82 was
shifted slightly upfield, while the methine proton in 85 was slightly downfield due to its
location nearer to the ketone carbonyl group. A proposed mechanism to explain the
appearance o f compound 85 in the chain extension-iodomethylation reaction is illustrated
in Scheme 19.
An assumption is made that the starting P-keto ester has not completely finished
undergoing the chain extension reaction before addition o f TMS chloride to the reaction
mixture. This means it is possible for remaining P-keto ester enolate to react with TMSC1,
which leads to the formation o f TMS enol ether 6. This intermediate could be converted
to the constitutional isomer 7 because o f the migrating ability o f silicon.3 After reacting
with the zinc carbenoid, the TMS-protected cyclopropyl alcohol intermediate 8 could be
presented in the reaction mixture. This hypothesis is similar to Saigo’s chain extension
method described in chapter I (Scheme 2). Fragmentation o f intermediate 8 provides a
chain extended zinc species 90. Reaction o f 90 with TMS chloride and excess carbenoid
would provide the homoenolate 92, which could be converted to P-iodomethyl y-keto
ester 93 by introduction o f iodine to the reaction.
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Scheme 19. Proposed Mechanism o f Formation o f (3-Iodomethyl y-Keto Esters 93

In order to test this hypothesis, the chain extension time o f the reaction was
increased from 10 min to 30 min. This modification was used to allow all o f the starting
compound P-keto ester to be consumed completely before addition o f trimethylsilyl
chloride to the reaction. Use o f thin layer chromatography (TLC) technique can
effectively monitor the degree o f starting material consumption in the reaction. It was
observed from the *H NMR spectrum o f the crude reaction mixture that the amount o f
byproduct P-iodomethyl y-keto ester dramatically decreased, which supported this
proposed mechanism. However, no further evidence confirms the existence o f the
intermediates in this type o f iodomethylation reaction.
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Synthesis of a-Iodomethyl y-Keto Amides
Based on the successful formation o f a-iodomethyl y-keto esters, the zinc-mediated
chain extension iodomethylation was studied with P-keto amides as the starting materials.
Considering the inefficiency o f the chain extension methylation for secondary P-keto
amides,83 tertiary P-keto amides were viewed as more suitable starting materials for this
study. The selected P-keto amides were not commercially available, so they were
prepared by the reaction o f diketene with various amines (Scheme 20).34

NaHC0 3

Scheme 20. The Reaction o f Diketene with Different P-Keto Amides

The first P-keto amide utilized in the iodomethylation reaction was N,Ndiisopropyl-3-oxo-butyramide 94, which was derived from jV,jV-diisopropylamine.
Surprisingly, no desired product a-iodomethyl y-keto amide 96 was observed in the crude
reaction mixture when it was subjected to the iodomethylation conditions. Only a-iodo yketo amide 97 and the chain extended product 98 were observed (Scheme 21).
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a)

Et2 Zn, CH2 I2

96

b) cat. TMSC1 or TMSOTf
c)I 2
94

97

98

Scheme 21. The Iodomethylation Reaction with N, A-Diisopropyl-3-oxo-Butyramide 94

Attempts were made to produce the iodomethylation product o f the P-keto amide,
including a modification in the amount o f catalytic trimethylsilylchloride (TMSC1) from
0.2 equivalents to 1.0 equivalents, as well as lengthening the reaction time for
methylation from 45 min to 90 min. 'H-NMR spectra o f the crude reaction mixture
showed the major product was still the a-iodo y-keto amide 97. The desired a-iodomethyl
chain-extended product was not formed. As discussed before, the role o f the
trimethylsilylchloride in the tandem chain extension methylation reaction is believed to
promote fragmentation o f the dimeric species 23 and generate an activated nucleophile.
Another more powerful electrophlic TMS-source TM SOTf was used to promote the
formation o f a-methyl y-keto amide. This effort resulted in slightly higher yield o f the aiodo compound 97, yet no iodomethylated material was obtained.
In addition to TV,A-diisopropyl-3-oxo-butyramide 94, the iodomethylation reaction
was performed with another P-keto amide substrate, l-(l,3-dioxobutyl) pyrrolidine 95,
derived from pyrrolidine. The desired compound a-iodomethyl y-keto amide 99 was
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observed in the crude mixture, but the a-iodo y-keto amide 100 was still present in the
reaction mixture. The target compound 99 derived from pyrrolidine P-keto amide 95 was
isolated by column chromatography in only 12% yield (Scheme 22). Although similar
modifications applied to the reaction o f the diisopropylamide substrate were also carried
out with 95, no improvement in yield was achieved.

99 (12%)

a) Et2 Zn, CH2 I2

O

O

b) cat. TMSC1
c )I 2

O

95

I

O
100

Scheme 22. The Iodomethylation Reaction with l-(l,3-Dioxobutyl) pyrrolidine 95

Based on all o f the information obtained from the experiments, it was concluded
that the tandem zinc-mediated chain extension-iodomethylation reaction does not work
efficiently with some P-keto amides; however, this does not mean that all p-keto amides
would be unreactive, since earlier work by Hilgenkamp demonstrated that some P-keto
amides, such as an A, A-dimethyl-3-oxobutyramide, can be converted to the desired

Di

methyl y-keto amides using the tandem chain extension-methylation reaction.7 A likely
explanation for the failure o f A A-di isopropyl P-keto amide 94 and pyrrolidine P-keto
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amide 95 in the iodomethylation reaction is that the methylation reaction is somehow
hindered by the presence o f bulky amide substituents. The steric hindrance may obstruct
the ability o f the amide carbonyl to form the TMS enol ether by reaction with TMSC1.

Synthesis o f a-Iodomethyl y-Keto Imides
In an effort to broaden the scope o f the zinc-mediated chain extension
iodomethylation reaction, the methodology was applied to a P-keto imide starting
material, derived from an oxazolidinone precursor. Oxazolidinones derived from chiral
amino acids are frequently referred to as Evans’ auxiliaries, which have been used widely
if

for asymmetric synthesis.

The utility o f chiral oxazolidinone P-keto imides in the zinc-

mediated chain extension-aldol reactions has been investigated by Lai and Lin.36
Incorporation o f the chiral oxazolidinone onto an amino acid-derived starting material
has proven to be effective for formation o f the chiral P-keto imide used for
diastereoselective chain extension-aldol reactions. We felt the chiral auxiliary would be
attractive for the control o f stereochemistry at the a-carbon o f iodomethylation products.
Before introducing the chiral auxiliary P-keto imide to this study, an achiral
oxazolidinone P-keto imide was exposed to the chain extension iodomethylation reaction
conditions. The P-keto imide 101 can be generated in a yield o f 36% through reaction
between diketene and oxazolidinone in the presence o f strong base n-butyl lithium. The
iodomethylated compound 102 was isolated by column chromatography in 31% yield
(Scheme 23).
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102 (31%)

Scheme 23. Preparation o f an Oxazolidinone (3-Keto Imide 101 and Its Iodomethylated
Product 102

Previous studies reported by Lin36b showed that one predominant cyclopropanol
derivative was separated from the crude mixture when the chain extension-aldol reaction
was performed on a peptide-derived P-keto imide. A similar phenomenon occurred in the
chain extension-iodomethylation o f the oxazolidinone P-keto imide. The interpretation
was that the imide functional group enhanced the formation o f a TMS-enol ether
intermediate 104 due to its ability to react with the TMS group, which was available in
the reaction system, while the imide carbonyls chelated with zinc (II) in the chain
extension-aldol reaction. The proposed mechanism involves spontaneous alkylation o f
the TMS-enol ether 104 with the excess carbenoid.
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Scheme 24. Proposed Mechanism for Cyclopropanation

If the cyclopropyl alcohol was formed via this mechanism, the cyclopropyl alcohol
could be easily formed when performing the methylation reaction. The existence o f TMS
chloride might promote formation o f the TMS enol ether intermediate, which could attack
the zinc carbenoid to generate the cyclopropyl alcohol derivative through an
intramolecular cyclization process. Experimental data (Scheme 25) showed that the ratio
o f methylated product 108 to cyclopropanol 107 decreased significantly with the
increasing amount o f catalytic TMS chloride equivalents. This indicated that TMS
chloride played an important role in promoting the formation o f the byproduct
cyclopropyl alcohol. Furthermore, evidence also depicted that longer reaction time for the
methylation helped to generate the cyclopropyl side product. Limiting the amount o f

31

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

TMS chloride and limiting the reaction time would be necessary to maximize the yield o f
the desired iodomethylated compound and reduce cyclopropanol formation.

a) EtZnCH2l(5 equiv)
0°C, 30 min

\ TI

J
101

b)TM SCl(AorB)
0°C, 30 min

108

A= 0.2 equiv

3.5 (40%)

B= 0.4 equiv

0.7 (22%)

107

Scheme 25. Chain Extension Methylation on an Oxazolidinone (3-Keto Imide 101

Control o f stereochemistry at the a-carbon site is both essential and a challenge in
the preparation o f ketomethylene isosteres. In order to achieve stereo-controlled asubstitution, an approach which utilized a chiral P-keto imide was undertaken. Reduction
o f the amino acid L-phenylalanine 109 with borane dimethylsulfide followed by
sequential reactions with triphosgene and diketene, provided the chiral P-keto imide 112 .
The chiral P-keto imide was exposed to the same conditions as used in the
iodomethylation reaction o f compound 101. The synthetic route to a chiral a-iodomethyl
y-keto imide is illustrated on Scheme 26.
From integration o f the *H NMR spectrum o f the crude reaction mixture, it was
found that the ratio o f diastereoisomers o f a-iodomethyl y-keto imide 113 was over 5 to 1,
indicating that the chiral auxiliary o f the P-keto imide controls the stereochemistry at the
a-position in the chain extension iodomethylation reaction. However, the yield o f
compound 113 was only 26%.
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Scheme 26. Synthesis o f a-Iodomethyl y-Keto Imide 113 through Chain Extension
Iodomethylation Reaction

As anticipated before, due to the similarity with the achiral P-keto imide, a
considerable amount o f cyclopropyl alcohol

114 was alsoisolated

chromatography from the reaction mixture in a yield o f 28%.

by column

The diastereoisomeric

cyclopropanols were produced in a ratio (dr) o f over 19:1. In agreement with the previous
result that the TMSC1 promotes the formation o f cyclopropyl alcohol, the yield o f
isolated compound 114 was increased to 41% when the amount o f TMSC1 was increased
from 0.2 equivalents to 1.0 equivalents. Another modification to increase the yield o f
cyclopropyl alcohol 114 was to lengthen the reaction time o f the methylation prior to the
addition o f iodine to the reaction mixture. The data showed that the yield o f compound
114 increased when the methylation time was changed from 1 hr to 2 hr. In the meantime
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the amount of iodomethylated compound 113 decreased to a similar degree.

Table 3. Yields o f Compound 113 and 114
Entry

Compound 113

Compound 114

Methylation: 1 hr

26%

28%

Methylation: 2 hr

23%

35%

Methylation: 1 hr

20%

41%

TMSC1 = 0.2 equiv
TMSC1 - 1.0 equiv

It is unclear what factors effectively control the stereoselectivity o f the cyclopropyl
alcohol formation. In another words, it is unclear which diastereomer converts faster to
the cyclopropanol. When treating the compound 96 with diethylzinc for a couple o f hours,
no cyclopropyl alcohol 114 was observed in the reaction mixture.
One predominant isomer o f the cyclopropanol 114 was obtained using the chiral 0keto imide as the starting material. Since the cyclopropyl alcohol is a solid, it will be
possible to identify the relative configurations o f the product by X-ray crystallographic
analysis. Efforts to grow an X-ray quality crystal are underway. Fragmentation o f the
cyclopropane ring in 114 might provides access to a chiral homoenolate, which would be
o f great interest on organic synthesis. Interest in the cyclopropyl alcohol may also be
found in its use as a sp -hybridized transition state mimic for peptide hydrolysis.
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Incorporation of Side Chain on a-Carbon Site of an a-Iodomethyl y-Keto Ester
1) Palladium-catalyzed Cross-coupling Reaction
As described above, efficient formation o f peptide isosteres requires that
appropriate functional groups be installed as side chains. Preferably, these side chains
will have identical functionality and stereochemical orientation with those found in the
natural amino acids system. The successful preparation o f a-iodomethylated y-keto esters
provided an iodomethyl group at the a-carbon site. This iodomethyl substituent was
proposed to be useful for the a-side chain mimics due to the high reactivity o f iodide. A
strategy in which transmetallation-coupling reaction would be utilized to attach a variety
o f carbon skeletons to the a-iodomethyl group was proposed.
A transmetallation-coupling reaction, also called cross-coupling, involves the reaction
between an organometallic reagent R-M with an organic compound R ’-X, where X is a
leaving group activated by a transition metal like palladium or nickel.37

R-M + R ’-X

P d o rN l» R-R’

Scheme 27. Metal-catalyzed Cross-coupling Reaction

Due to the central importance o f coupling reactions in the formation o f new carboncarbon bonds in organic synthesis, cross-coupling reactions have been investigated
intensively over the last thirty years.38 Many transition metals are capable o f promoting
and catalyzing this type o f reaction, including palladium, copper, nickel and iron.
Palladium has proved to be the most broadly employed and powerful catalyst for
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•2Q

facilitating carbon-carbon bond formation through a variety o f cross-coupling reactions. ’
40

Palladium-catalyzed cross-coupling reactions would be expected to facilitate the goal

o f incorporating a-side chains that mimic those found in nature. Generally, iodides and
bromides have been used as the organic acceptors (carbon electrophile) in Pd-catalyzed
cross coupling reactions. A variety o f metals, including tin, zinc, aluminum, boron or
silicon, can be employed as the organometallic donors in this type o f reaction. To
investigate the Pd-catalyzed cross-coupling reaction on the iodomethylated y-keto
product 82, a Negishi coupling reaction 41 was utilized to this study. The palladium
complex tris (dibenzyllideneacetone)dipalladium was selected as the catalyst in
collaboration with the tri-(o-tolyl)phosphine ligand. Zinc metal also was introduced to
make the organozinc compound from the iodomethylated material 82. Since aryl iodides
are generally more reactive than bromides or chlorides with the zero valent palladium
'y

complex, different sp -hybridized iodides were employed in this study. The Pd-catalyzed
Negishi cross-coupling reaction is considered to proceed via a catalytic cycle, as
summarized in Scheme 28.
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Pd°L4
Activation

R

r _j

Oxidative Addition

Reductive Elimination

R'-ZnI
Transmetallation

Trans/Cis Isomerization

Scheme 28. Proposed Mechanism o f Pd-catalyzed Negishi Coupling Reaction

The procedure was carried out by exposing the a-iodomethyl y-keto ester 82 to the
mixture o f zinc dust (1.4 equiv.) and a small amount o f iodine in DMF at 0 °C for 30 min
under a nitrogen atmosphere to produce a solution o f an intermediate organozinc reagent.
The iodobenzene derivative (1.2 equiv.), tris (dibenzyllideneacetone)dipalladium(O) (0.05
equiv.), and tri-(o-tolyl)phosphine (0.2 equiv.) were added to the reaction mixture. The
reaction mixture was heated to 60 °C and stirred for 5 h with the cross-coupling reaction
taking place through the action o f the palladium catalyst.42 In order to investigate the
generality o f the cross-coupling reaction with the chain extended system, different sp2hybridized iodides were used in the cross-coupling reaction. Some o f these compounds
were selected since they possess similar functional groups to those found in the skeleton
o f peptide inhibitors, such as Ruprintrivir,43 and natural amino acids, like L-leucine.

37

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

R

a) Zn, I2

0°C, 30 min

O
Pd2dba3, P(o-Tol)3

82

DMF, 60°C, 5 h
115 R = H: 30%
116 R = Cl: 25%

Scheme 29. Preparation o f a-Alkylated y-Keto Ester via Pd-catalyzed Negishi Coupling
Reaction

The first effort to form an a-alkylated y-keto ester through a Pd-catalyzed Negishicoupling reaction utilized a-iodomethyl y-keto ester 82 and iodobenzene (Scheme 29).
The desired a-alkylated compound was separated successfully from the crude mixture
after column chromatography. Compound 115 can be used to mimic the side chain o f the
amino acid phenylalanine. Compared with the organic synthesis procedure reported by
Jackson et al42, in which a similar procedure was used (Scheme 30) to produce a coupling
product from 35% to 39% yield, the 30% yield for the formation o f the a-alkylated y-keto
ester 115 is not unexpected.
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BocHN

C02Me

B o cH N ^ ^ C 0 2Me 1)Zn

COjMe

Pd2dba3, P(o-Tol)3

C02Me

DMF, 60°C

Scheme 30. Synthesis o f AL(fer/-Butoxycarbonyl)-P-[4-(methoxycarbonyl)benyl]alanine
Methyl Ester

Another aromatic iodide derivative, l-chloro-4-iodobenzene was also employed in
this type o f cross-coupling reaction with the same a-iodomethyl y-keto ester 82. Pure aalkylated y-keto ester 116 was obtained in a 25% yield.
Since the organozinc intermediate, which would be used in the following cross
coupling reaction, was generated in the methylation process without addition o f iodine, in
order to simplify the steps o f these reactions, an one-step o f chain extension methylationPd-catalyzed cross-coupling reaction was attempted. Toluene was used as a solvent in the
chain extension methylation reaction instead o f dichloromethane. The cross-coupling
reaction was preformed between the unisolated organozinc intermediate and iodobenzene
under similar conditions. No desired a-alkylated compound 115 was obtained by column
chromatography. The major product was a-methylated y-keto ester 36. It indicated the
cross-coupling does not take place under this one-step procedure (Scheme 31).
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ZnX
b) TMSC1

115

35

Scheme 31. Attempted One-step Pd-catalyzed Cross-coupling Reaction

The a-alkylated y-keto ester that was incorporated with iodophenol, which could
mimic the side group o f the amino acid tyrosine, was expected to be generated through
the Pd-catalyzed cross-coupling reaction. Because the acidic proton on iodophenol would
quench the zinc intermediate generated in-situ by zinc insertion o f a-iodomethyl y-keto
ester 82, protection o f the OH group was required. t-Butyldimethylsilyl chloride was used
to protect the iodophenol (Scheme 32) in the study.44

OTBDMS
TBDMSC1
pyridine

pyridine

Scheme 32. Protection o f Iodophenol with TBDMSC1 and Acetic Anhydride

The effort to produce compound 119 (Scheme 33) in the cross-coupling reaction
was failed. No targeted compound was observed in the crude reaction mixture or after
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column separation. When compound 82 was only treated with zinc dust and a small
amount o f iodine, the a-methyl y-keto ester 87 was generated from the aqueous quench o f
the organozinc intermediate. This study indicated that the zinc insertion process was
successful in the first step o f the reaction. Some modifications were attempted in the
cross-coupling reaction, including increasing the reaction time from 5 h to 24 h, and
using an acetyl protecting group (with better electron withdrawing capability) instead o f
the TBDMS group. No evidence for the formation o f the target compound in the reaction
mixture was found. The oxygen donates electron density to the aromatic ring, which may
play a role in hindering palladium insertion into the iodophenol, thus resulting in the
failure o f new carbon-carbon bond formation.

.OPG

■OPG

82

PG = TBDMS 119 or Acetyl 120

Scheme 33. Attempted Preparation o f a-Alkylated y-Keto Ester with Protected
Iodophenol via Pd-catalyzed Cross-coupling Reaction

In addition to the study o f the a-iodomethylated y-keto ester 82, the Pd-catalyzed
cross-coupling reaction between a-iodomethyl y-keto imide

102

and iodobenzene was

also studied. The same procedure was followed as described above (Scheme 34). The
desired coupled compound

121

was successfully isolated from the crude reaction mixture

in a yield o f 23%.
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Pd2dba3, P(0 -Tol)3

102

DMF, 60°C, 5 h

121

Scheme 34. Preparation o f a-Alkylated y-Keto Imide 119 via Pd-catalyzed Negishi
Coupling Reaction

In order to expand the scope o f the cross-coupling reaction as applied to the aiodomethylated y-keto ester system, another substrate, 2-bromopropene, was utilized. The
reaction with a-iodomethyl y-keto ester 82 followed a similar procedure as described for
the aryl iodides. Since 2-bromopropene has a low boiling point (42-47 °C), careful
control o f reaction conditions was required. The desired a-alkylated y-keto ester 122 was
successfully obtained in a 25% yield. Because the compound 122 incorporated a new
carbon-carbon double bond in its molecular structure, it was possible to further
manipulate the a-substituent. Treatment o f 122 with hydrogen in the presence o f
palladium on carbon provided compound 123, which was easily isolated by column
chromatography using a pipette. Compound 123 contains a side chain that effectively
mimics the side chain o f the amino acid leucine. All o f the information gained from these
methodological studies suggests that the zinc-mediated chain extension-iodomethylation
product provides an opportunity to incorporate a substituent at the a-carbon site o f the
extended chain, thereby facilitating the regio-controlled a-substitution for the efficient
mimicry o f peptide systems.

42

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

DM F, 40 °C, overnight

82

122 (25%)

123 (59%)

Scheme 35. Preparation o f the Compound 122 and 123

2) Attempted Synthesis of a Ketomethylene Isostere
Based upon the successful results from the study on the chain extension
iodomethylation methodology and in order to demonstrate the utility o f the tandem chain
extension-iodomethylation chemistry, the preparation o f ketomethylene isostere 124,
which is a key component o f peptide inhibitor Ruprintrivir 125, was proposed. The
proposed synthetic approach is illustrated in Scheme 36.

ch3

Pmb.

'f > T

Cbz

F

Ruprotrivir 125

Figure 3. The Ketomethylene Isostere 124 and Ruprintrivir 125
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L-Valine was selected as starting material for the synthesis o f target 124. Since
tandem chain extension-iodomethylation reactions are sensitive to the presence o f a
proton source, which would quench the enolate and/or homoenolate prior to the
introduction o f iodine, appropriate protection o f the amino acid is required. Previous
studies on the protection o f amino acids were carried out by Tryder45 and Lin.36b A variety
o f protecting groups used for amino acids have been shown to be tolerated in the chain
extension reaction; therefore, an effective two-step protection sequence was developed.
The first step involved protection with a /?ara-methoxybenzyl group (Pmb) through
treatment o f L-valine with />anisaldehyde, followed by reduction using sodium
borohydride. The Pmb-protected amino acid 126 was produced in a good yield. However,
the nucleophilic nitrogen atom was assumed to be incorporatible with the electrophilic
carbenoid used in the chain extension reaction, so further protection on the amino group
was needed. The carbobenzyloxy (Cbz) group is a very common protecting group for
amino acids in peptide synthesis, and was believed to be suitable for protecting the amine
group to its electron withdrawing character. Incorporation o f the Cbz group onto the
Pmb-protected amino acid 126 proceeds in an aqueous sodium hydroxide solution, which
is used to scavenge the HC1 generated from the reaction o f Cbz chloride and amine. The
TV-protected amino acid 127 was obtained in a good yield.
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a) /7-anisaldehyde
NaOH
>

Cbz-Cl

Pmb

Pmb.

NaOH

b) NaBH4

L-vahne

127 (80%)

126(73%)

Bn
a) CDI
'N'

O
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a) Et2Zn, CH2 I 2
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b) LDA,

AA
)A

Cbz

o

h°

O

O

b) TMSC1

c)I 2

Pmb
*
Cbz

o

Bn

130(46%)

129 (60%)

128

a) Zn, I;

NaOMe

Pmb.
b) 1-fluoro-4-iodobenzene
Pd2dba3 P(0-Tol)3, DMF

Cbz

Pmb.
Cbz

Bn

F
124

131

Scheme 36. Attempted Synthetic Approach to a Ketomethylene Isostere 124

In this synthetic route to target compound 124, the key step was to prepare the
desired chiral P-keto imide 129 that could be used as a substrate in the zinc-mediated
chain

extension-iodomethylation

and

Pd-catalyzed

cross-coupling

reaction.

The

generation o f the P-keto imide from amino acid was performed through a modified
Claisen condensation using a method developed by Lin (Scheme 38).

Activation o f the

protected-valine through treatment with carbonyl diimidazole at room temperature in

45

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

THF formed acyl imidazole 132. Then the acyl imidazole solution was transferred to
another solution, in which the iV-acetylated oxazolidinone 128 had been deprotonated by
lithium diisopropylamide (LDA) to form an enolate intermediate. The chiral P-keto imide
129 was generated in a reasonable yield. The preparation o f Compound 128 is shown in
Scheme 37.

O
BF3 'OEt2 ,
HO

ho/

X /N H

BH3 •SM e2

(ci3co)2cq
n-BuLi

Bn

Bn

2

D-phenylalanine

1

c h 3c o c i

^

J
O

n-BuLi

\

°

o

L

X
N'
/

Bn

Bn
128

Scheme 37. Preparation o f Compound 128 from D-phenylalanine

Self-condensation o f compound 128 during treatment with LDA occurs under these
reaction conditions, so slow addition o f compound 128 to the LDA solution was crucial
to achieve efficient formation o f 129. On the other hand, the acidic character o f 129
presents ability to quench the enolate intermediate. The imidazole byproduct 133,
generated from the activation o f the acid, can also act as a proton source to consume the
enolate during the reaction process, so in order to maximize the yield o f chiral P-keto
imide 129 a 3:1 ratio o f enolate intermediate 134 to protected acid 132 was required.

46

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Scheme 38. Synthesis o f Chiral P-Keto Imide 129 through a Modified Claisen
Condensation Reaction

The zinc-mediated chain extension-iodomethylation reaction was conducted on the
chiral P-keto imide 129 to generate the corresponding a-iodomethyl y-keto imide 130 in a
yield o f 46% under the same conditions as used with previous P-keto imides. The *H
NMR spectrum o f the purified compound 130 was difficult to interpret, due to the
1 -j

coexistence o f rotamers and diastereomers. The
peak (chemical shift

8

C NMR spectrum revealed an upfield

4.7), which corresponded to a carbon attached to an iodine atom.

This peak was characteristic in all o f the a-iodomethylated y-keto compounds prepared in
this study. Evidence from the MS spectrum (ESI) also strongly supported the conclusion
that 130 was indeed obtained through the iodomethylation reaction, in which the value o f
the largest peak (m/z 749) was consistent with the molecular weight (726) o f 130 plus a
sodium ion (23). The ratio o f diastereoiosomers and absolute configuration o f the acarbon is still unknown. Further study on the stereo-controlled iodomethylation is
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required.
Unfortunately no cross-coupling product 131 was generated when compound 130
was reacted with l-fluoro-4-iodobenzene. The complicated structure o f compound 130
might be a factor in inhibiting the coupling reaction. Therefore the a-iodomethyl y-keto
ester 82 was used in a cross-coupling reaction with l-fluoro-4-iodobenzene (Scheme 39).
No coupling product 135 was observed in this reaction, although the side products ahydroxymethyl y-keto ester 136 and tri-(o-tolyl)phosphine oxide 137 were shown to be
present in the reaction mixture by NMR and MS spectroscopy. These results suggest that
l-fluoro-4-iodobenzene does not participate in this cross-coupling reaction; however
further investigation o f this question needs to be carried out in the future.

F

Pd2dba3, P(o-Tol)3
82

135

DMF, 60°C, 5 h

OH

136

137

Scheme 39. Attempted Synthesis o f a- Alkylated y-Keto Ester 135 with l-Fluoro-4Iodobenzene and Side Products 136 and 137
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3) Other Applications
As described earlier in chapter II, the anticipated high reactivity o f the iodide
formed in the product o f zinc-mediated chain extension-iodomethylation reaction could
be used to attach different groups to the a-position, thereby mimicking the side chain o f
natural amino acids such as cysteine and glutamic acid.
A previous attempt to make a ketomethylene peptide mimic with cysteine-like side
chain was made by Emerald Wilson in the Zercher research group .46 The data showed the
a-iodomethyl y-keto ester 82 did not react with thiourea to make an isothiuronium salt
138, which presumably could have been converted to a cysteine derivative 139. The
methylated material 87 was identified by 'H NMR as well as other byproducts (Scheme
40).

87

Scheme 40. Attempted Formation o f Isothiumium Salt 138

Alternative nucleophilic sulfur reagents were investigated for the preparation o f the
compound 139 in the present study, including sodium sulfide and sodium hydrogen
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sulfide. The literature reports that several pathways have been used for the preparation o f
thiols from iodides .47 Since sulfur-containing compounds are easily oxidized and thiols
are excellent nucleophiles, excess amounts o f Na 2 S or NaSH (10 equiv.) were employed
in these thiolation reactions to avoid the formation o f thioether 140 and dimeric species
141. Unfortunately, the major compound identified by *H NMR and MS (ESI) analyses
was the thioether 140 rather than the desired compound 139. The isolated yield o f 140
was about 28-30%. The minor dimeric form o f compound 141 was isolated from the
crude mixture, which was readily converted to 139. The limited solubility o f the sodium
salts slowed its participation as a nucleophile, while the thiolate intermediate was nicely
soluble; therefore formation o f 140 was difficult to avoid. Modifications, including an
attempt to increase the solubility o f Na 2 S by using more solvent (DMF) or by using a
solvent mixture o f DMF and H 2 O did not result in any improvement.

Na?S or NaSH
DMF

82

141

140

Scheme 41. Formation o f Thioether 140 and Dimeric Species 141 o f Compound 139

Due to the unsatisfactory result described above, an alternative approach to the
incorporation o f a sulfur on the side chain was attempted. Treatment o f iodide 82 with
AO

potassium thioacetate provided the acetyl-protected thiol 142.

Conversion o f the
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protected sulfur compound 142 to the target compound 139 was attempted through
removal o f the acetyl group using sodium methoxide in a methanol solution (Scheme 42).
Surprisingly, no desired compound 139 was observed in the crude mixture. The presence
o f compounds 140 and 141 were identified by mass spectrum. Moreover, compound 139
was not observed from mass spectral data o f the crude reaction mixture during the
reaction period. Although the acetyl group was never successfully removed in this study,
its removal is well precedented.48c This strategy o f iodide displacement with a sulfur
nucleophile provides access to the peptide isosteres with cysteine-like side chains

SH
NaOMe
THF

82

MeOH

142 (65%)

Scheme 42. Attempted Formation o f Compound 139 Using Protected Sulfur Compound
142

The product o f the tandem zinc-mediated chain extension-iodomethylation reaction
could also be used to install a carboxylate functionality on the a-carbon site o f the
extended chain through nucleophilic alkylation. An initial study on this application was
conducted through the use o f dimethyl malonate. The dimethyl malonate was treated with
a strong base and reacted with the a-iodomethyl y-keto ester 82 to generate a-alkylated
compound 143, which could be converted to compound 144 by further decarboxylation
(Scheme 43).49 The decarboxylated product would mimic the side group o f glutamic acid.
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The compound 141 was successfully obtained using this strategy; however, the
coexistence o f three methyl ester groups in the same molecule provides a challenge for
the subsequent ester cleavage and decarboxylation. The use o f an alternative malonate
reagent with easily removable ester groups, such as benzyl t-butyl malonate, would be
preferred for improving selectivity in the ester cleavage and decarboxylation.

COOH

o
q

decarboxylation

K-BuLi
Dimethyl Malonate

O
82

143

144

Scheme 43. Nucleophilic Alkylation on Compound 82

In summary, the products formed in the tandem chain extension iodomethylation
reaction could be utilized in subsequent chemistry, which provides a facile means to form
side chains suitable for peptide isosteric replacements.
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CHAPTER III

CONCLUSION

A new efficient methodology for the preparation o f a-substituted y-keto esters,
amides and amino acid-derived imides has been developed. A tandem zinc-mediated
chain extension-iodomethylation reaction, which is derived from the zinc-mediated chain
extension methylation reaction, has been successfully applied to a variety o f P-keto esters,
amides and imides. This one-pot approach containing three distinct steps facilitates the
efficient preparation o f ketomethylene isosteres, which are proven inhibitors for various
enzymatic systems. The yields for the formation o f a-iodomethyl y-keto esters were
higher than for the formation o f a-iodomethyl y-keto amides. p-Keto amides with bulky
groups on the amide bond did not react efficiently under the zinc-mediated chain
extension-iodomethylation reaction conditions.
Evidence showed that exposure o f a chiral P-keto imide to the chain
extension-iodomethylation reaction conditions provides an a-iodomethyl y-keto product
with high diastereoselectivity (de>80%). Furthermore, one predominant isomer o f a
cyclopropane product was obtained from the chiral P-keto imide. When an increase in the
amount o f catalytic TMSC1 was used, an improved yield o f the cyclopropanol was
realized. The absolute configuration o f the a-position o f the cyclopropanol isomer has not
been assigned. These data indicate that a chiral

P-keto imide promotes the

stereocontrolled incorporation o f substituents at the a-position o f the extended chain.
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It is believed that the mechanism o f the zinc-mediated chain extension
-iodomethylation reaction involves a donor-acceptor cyclopropane intermediate, which
fragments to provide a zinc enolate intermediate. Exposure o f the zinc enolate to TMS-C1
promotes the formation o f a reactive TMS enol ether, which reacts with another
equivalent o f the zinc carbenoid to generate a zinc homoenolate. This zinc homoenolate
can be utilized in further tandem reaction processes to generate products which possess
an appropriately positioned a-side chain for the effective mimicry o f peptide bonds.
Different substrates were successfully incorporated to generate a-sustituted y-keto esters
and imides in modest yields.
In one application o f the homoenolate-derived product, a palladium-catalyzed
cross-coupling reaction was used to derivitize the a-iodomethylated product. The
cross-coupling reaction facilitated the incorporation o f a a-substitution suitable for
peptide isosteres; however, some aromatic halides, including iodophenol and

1 -fluoro-

4-iodobenzene, did not react with the a-iodomethylated product in this palladiumcatalyzed cross-coupling reaction.
The a-iodomethylated products were utilized as substrates in other applications,
such as thiolation and nucleophilic alkylations, to attach different alkyl groups at the
a-position.
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CHAPTER IV

EXPERIMENTAL SECTION

1.

General Experimental
Unless otherwise noted, all reactions were run in oven-dried glassware and stirred

with teflon-coated magnetic stir-bars. The term concentrated under reduced pressure
refers to the use o f a rotary-evaporator or vacuum pump.

a)

Solvents
Methylene chloride (CH 2 CI2 ), tetrahydrofuran (THF), diethyl ether (Et2 0 ),

AUV-dimethylformamide (DMF) and methanol were dried by passing the solvent through
a column o f alumius or molecular sieves using an Inovative Technology Inc. solvent
delivery system. Ethyl acetate (EtOAc) and hexanes used for chromatography were
purchased from Pharmco and distilled prior to use.

b)

Reagents
Unless otherwise noted, all reagents were purchased from commercial suppliers and

used without further purification. Diethylzinc was purchased both as a solution (1.0 M in
hexane) and neat. Methylene iodide (CH 2 I2 ) was purchased from Lancaster Chemical.
Non-oxidized copper wire was added as a stabilizer. Iodine was sublimed prior to use.
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Trimethylsilylchloride (TMS-C1) was distillated from calcium hydride under a nitrogen
environment and stored over 4

A sieves.

Tris(dibenzyllideneacetone)dipalladium(0)

and

tri-(o-tolyl)phosphine

were

purchased from Aldrich Chemical Co. and used without further purification. Palladium
10% on carbon was purchased from Aldrich Chemical Co. and used without purification.

c)

Chromatography
Column chromatography was performed with Sorbent Technologies flash silica gel

(32-63 pm). The mobile phase was prepared as noted in the individual experimental
section. Thin Layer Chromatography (TLC) was carried out on EM Science F254 glass
plates and visualized by UV and anisaldehyde or KMnC>4 stains.

d)

Spectroscopy
Nuclear Magnetic Resonance (NMR) spectroscopy was performed on Varian

Mercury operating at 399.768 MHz for 'H nuclei and 100.522 MHz for 13C nuclei, and
Varian Inova operating at 499.766 MHz for ]H nuclei and 125.679 MHz for I3C nuclei.
1 o

All

1

C are H-decoupled. Unless otherwise noted, all NMR experiments were carried out

in deuterochloroform (CDCI3 ) solvent purchased from Cambridge Isotope Laboratory
and stored over 4

A

sieves. All chemical shifts are reported in parts per million (ppm)

downfield o f tetramethylsilane (TMS) internal standard.
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Mass Spectrometry (Electronic Scanning Ionization) was performed on a Thermo
Finnigan LCD instrument. Mass Spectrometry (Matrix Assisted Laser Desorption
Ionization) was performed on an Axima instrument. Infrared spectroscopy was performed
on a Nicolet 205 Fourier Transform spectrometer.

e)

Experimentation
Melting points were determined using an Electrothermal 9100 digital melting point

apparatus and are uncorrected. Optical rotations were conducted using a Rudolph
Research AUTOPOL III automatic polarimeter in specified solution and concentrations
are given in g/mL.

2.

Preparation of a-Iodomethyl y-Keto Esters

2-Iodomethyl-5, 5-dimethyl-4-oxo-hexanoic acid methyl ester 82
An oven-dried, one-necked, 50-mL round-bottomed flask equipped with a rubber
septum and magnetic stir-bar was cooled to room temperature under a nitrogen
atmosphere, and charged with 15 mL o f methylene chloride. The solvent was cooled to
0 °C in an ice bath and methylene iodide (0.32 mL, 4.0 mmol) was added dropwise into
the flask. Diethyl zinc (4.0 mL, 1.0 M in hexane, 4.0 mmol) was added slowly to the
reaction mixture at 0 °C over two min. The resulting white suspension was stirred for 10
min, and then methyl pivaloylacetate (0.16 mL, 1.0 mmol) was added rapidly. After the
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solution was stirred for 30 min, trimethylsilylchloride (25 |iL, 0.2 mmol) was added in
one portion by micro-syringe. The mixture was allowed to stir for 45 min at room
temperature followed by the addition o f iodine (1.269 g, 5.0 mmol) to the reaction
mixture. The reaction mixture quickly became a pink suspension and was stirred for 10
min, quenched with 10 mL o f saturated aqueous ammonium chloride, and extracted with
diethyl ether (3x10 mL). The combined organic layers were washed with saturated
sodium thiosulfate solution (2x15 mL), and brine (3x20 mL), dried over anhydrous
sodium sulfate, fdtered, and concentrated under reduced pressure (25 °C, 30 torr). The
residue was purified by column chromatography on silica (30:1, hexane: ethyl acetate, R/
= 0.16) to yield 0.128 g (41%) o f 2-iodomethyl-5,5-dimethyl-4-oxo-hexanoic acid methyl
ester 82 as a clear yellow liquid. ]H NMR (400 MHz, CDCI3)

8

3.73 (s, 3 H), 3.45 (dd,

J = 6.0, 10.0 Hz, 1 H), 3.38 (dd, 7 = 5.4, 10.0 Hz, 1 H), 3.20 (m, 1 H), 3.11 (dd, J = 7.0,
17.9 Hz, 1 H), 2.80 (dd, J = 5.4, 18.0 Hz, 1 H), 1.18 (s, 9 H); 13C NMR (100 MHz,
CDCI3 ) 5 213.3, 172.5, 52.6, 44.3, 42.0, 39.2, 26.8, 6.3; IR (neat, cm '1): 2967, 1738,
1705, 1477, 1366, 1232.

2-Iodomethyl-4-oxo-pentanoic acid tert-butyl ester 83
An oven-dried, one-necked, 50-mL round-bottomed flask equipped with a rubber

septum and magnetic stir-bar was cooled to room temperature under a nitrogen
atmosphere, and charged with 15 mL o f methylene chloride. The solvent was cooled to
0 °C in an ice bath and methylene iodide (0.32 mL, 4.0 mmol) was added dropwise into
58
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the flask. Diethyl zinc (4.0 mL, 1.0 M in hexane, 4.0 mmol) was added slowly to the
reaction mixture at 0 °C over two min. The resulting white suspension was stirred for 20
min, and then t-butyl acetoacetate (0.17 mL, 1.0 mmol) was added rapidly. After the
solution was stirred for 30 min, trimethylsilylchloride (25 pL, 0.2 mmol) was added in
one portion by micro-syringe. The mixture was allowed to stir for 45 min at room
temperature followed by the addition o f iodine (1.269 g, 5.0 mmol) to the reaction
mixture. The reaction mixture quickly became a pink suspension and was stirred for 10
min, quenched with 10 mL o f saturated aqueous ammonium chloride, and extracted with
diethyl ether (3x10 mL). The combined organic layers were washed with saturated
sodium thiosulfate solution (2x15 mL), and brine (3x20 mL), dried over anhydrous
sodium sulfate, filtered, and concentrated under reduced pressure (25 °C, 30 torr). The
residue was purified by column chromatography on silica (15:1, hexane: ethyl acetate, R/
= 0.15) to yield 0.201 g (63%) o f 2-iodomethyl-4-oxo-pentanoic acid tert-bu\y\ ester 83
as a clear yellow liquid. !H NMR (400 MHz, CDC13)

6

3.46 (dd, J = 5.6, 9.9 Hz, 1 H),

3.35 (dd, J = 4.4, 9.9 Hz, 1 H), 3.07 (m, 1 H), 3.00 (dd, J = 5.5, 17.6 Hz, 1 H), 2.62 (dd, J
= 5.0, 17.6 Hz, 1 H), 2.20 (s, 3H), 1.46 (s, 9 H); 13C NMR (100 MHz, CDC13) 5 206.0,
170.8, 82.0, 45.3, 42.5, 30.4, 28.1, 7.3.
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2-Iodomethyl-4-oxo-pentanoic acid benzyl ester 84
An oven-dried, one-necked, 50-mL round-bottomed flask equipped with a rubber
septum and magnetic stir-bar was cooled to room temperature under a nitrogen
atmosphere, and charged with 15 mL o f methylene chloride. The solvent was cooled to
0 °C in an ice bath and methylene iodide (0.32 mL, 4.0 mmol) was added dropwise into
the flask. Diethyl zinc (4.0 mL, 1.0 M in hexane, 4.0 mmol) was added slowly to the
reaction mixture at 0 °C over two min. The resulting white suspension was stirred for 10
min, and then benzyl acetoacetate (0.18 mL, 1.0 mmol) was added rapidly. After the
solution was stirred for 30 min, trimethylsilylchloride (25 pL, 0.2 mmol) was added in
one portion by micro-syringe. The mixture was allowed to stir for 45 min at room
temperature followed by the addition o f iodine (1.269 g, 5.0 mmol) to the reaction
mixture. The reaction mixture quickly became a pink suspension and was stirred for 10
min, quenched with 10 mL o f saturated aqueous ammonium chloride, and extracted with
diethyl ether (3x10 mL). The combined organic layers were washed with saturated
sodium thiosulfate solution (2x15 mL), and brine (3x20 mL), dried over anhydrous
sodium sulfate, filtered, and concentrated under reduced pressure (25 °C, 30 torr). The
residue was purified by column chromatography on silica (25:1, hexane: ethyl acetate, R/
= 0.21) to yield 0.208 g (58%) o f 2-iodomethyl-4-oxo-pentanoic acid benzyl ester 84 as a
clear yellow liquid. *H NMR (400 MHz, CDCI3) 8 7.36 (s, 5 H), 5.15-5.14 (m, 2 H), 3.48
(dd, J = 7.5, 11.4 Hz, 1 H), 3.39 (dd, J = 4.6, 10.1 Hz, 1 H), 3.23 (m, 1 H), 3.06 (dd, 7 =
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CDC13) 5 205.8, 171.7, 135.6, 128.8, 128.7, 67.5, 45.3, 41.9, 30.4, 6.1.

3.

Preparation of P-Keto Amides

N, TV-Diisopropyl-3-oxo-butyramide 94
An one-necked, 50-mL round-bottomed flask equipped with a rubber septum and
magnetic stir-bar was charged with 15 mL o f deionized water. iV,iV-Diisopropylamine
(2.8 mL, 20 mmol) and diketene (2.3 mL, 30 mmol) were added into the reaction flask.
The reaction mixture was stirred at room temperature for 4 h, quenched with 10 mL o f
saturated citric acid solution, and extracted with ethyl acetate (3 x 2 0 mL). The combined
organic layers were washed with saturated sodium bicarbonate solution (2x10 mL), and
brine (3x15 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under
reduced pressure. The residue was purified by column chromatography on silica (9:1,
hexane: ethyl acetate, R / = 0.25) to yield 1.54 g (42%) o f A/,7V-diisopropyl-3-oxobutyramide 94 as a clear orange liquid. The dicarbonyl was in equilibrium with the enol
form. JH NMR (400 MHz, CDC13) 5 3.49 (s, 2 H), 2.26 (s, 3 H), 1.40 (d, J =
H), 1.19 (d, J = 6.7 Hz,
6

6

H), 1.19 (d, J = 6.7 Hz,

H); enol form:
6

8

6 .8

5.10 (s, 1 H),. 1.96 (s, 3 H), 1.40 (d, J =

H); 13C NMR (100 MHz, CDC13)

8

Hz,

6 .8

6

Hz,

203.3, 165.7, 52.6, 50.0,

46.2,30.2,20.9,20.6.
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1-Pyrrolidin-l-yl-butane-l, 3-dione 95
A two-necked, 100-mL round-bottomed flask equipped with a reflux condenser and
magnetic stir-bar was charged with 30 mL o f deionized water, sodium bicarbonate (2.52
g, 30.0 mmol) and pyrrolidine (1.7 mL, 20.0 mmol). Diketene (2.3 mL, 30.0 mmol) was
added to the flask dropwise. The reaction mixture was allowed to heat to 50 °C in water
bath, and stirred for 2 h. The reaction was stirred at room temperature overnight, then
quenched with 10 mL o f saturated citric acid solution, extracted with ethyl acetate (3><20
mL). The combined organic layers were washed with saturated sodium bicarbonate
solution (2 x

ml), and brine (3 x 1 5 ml), dried over anhydrous sodium sulfate, filtered,

10

and concentrated under reduced pressure. The residue was purified by column
chromatography on silica (ethyl acetate, R / = 0.51) to yield 0.62 g (20%) o f
1-pyrrolidin-l-yl-butane-1,3-dione 95 as a clear orange liquid. Enol form was also
present. *H NMR (400 MHz, CDC13)
H); enol form:

8

8

3.49-3.40 (m,

6

H)), 2.29 (s, 3 H), 2.00-1.85 (m, 4

4.99 (s, 1H), 3.49-3.40 (m, 4 H)), 1.95 (s, 3 H), 2.00-1.85 (m, 4 H); 13C

NMR (100 MHz, CDC13)

8

202.6, 165.1, 51.5, 47.3, 45.9, 30.5, 26.1, 24.6, enol form:

8

174.2, 170.4, 88.9, 46.2, 45.0, 26.0, 21.7. IR (neat, cm '1): 2975, 2880, 1717, 1626, 1454,
1361.
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4.

Preparation of a chiral P-Keto imide

l-((5) 4-Benzyl-2-oxo-oxazolidin-3-yl)-butane-l, 3-dione 112
An oven-dried, one-necked, 100-mL round-bottomed flask equipped with a rubber
septum and magnetic stir-bar was cooled to room temperature under a nitrogen
atmosphere, and charged with a solution o f (S)-4-benzyl-oxazolidin-2-one (1.4 g, 8.0
mmol) in 50 mL o f anhydrous tetrahydrofuran. The THF solution was cooled to -78 °C
and n-butyl lithium (4.0 mL, 10.0 mmol o f a 2.5 M solution in hexane) was added
dropwise to the flask. After the completion o f the addition, the reaction mixture was
warmed to 0 °C for 10 min. The mixture was cooled to -78 °C again, and diketene (1.23
mL, 16.0 mmol) was added slowly to the mixture. The resultant orange solution was
maintained at -78 °C for an additional 30 min after the addition was complete, and then
allowed to stir at 0 °C for 2 h. The mixture was quenched with 15 mL o f saturated NH 4 CI
solution and concentrated under reduced pressure (25 °C, 18 torr) to remove the solvent
THF. The residue was extracted by methylene chloride (3><20 mL), and the combined
organic layers were washed with sat. NaHCC>3 solution (2x20 mL) and brine (3x20 mL),
dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure.
The residue was purified by column chromatography on silica (4:1, hexane: ethyl acetate,
R/

=

0.14)

to

yield

0.80

g

(38%)

of

1-((*S)

4-benzyl-2-oxo

-oxazolidin-3-yl)-butane-l,3-dione 112 as a light yellow solid, mp 67-68.5 °C;

'H NMR

(400 MHz, CDCI3 ) 5 7.36-7.22 (m, 5 H), 4.72 (m, 1 H), 4.25-4.16 (m, 2 H ), 4.11-4.06
(m, 2 H), 3.37 (dd, J = 3.4, 13.5 Hz, 1 H), 2.80 (dd, 7 = 9.6, 13.5 Hz, 1 H), 2.29 (s, 3 H);
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13C NMR (100 MHz, CDC13) S 201.1, 166.6, 153.9, 135.3, 129.7, 129.2, 127.6,

6 6 .6

,

55.2, 51.6, 38.4, 30.4; enol form: 5 180.5, 153.9, 135.3, 129.7, 129.2, 127.6, 90.1, 66.3,
54.9,38.4,22.4.

5.

Preparation of a-Iodomethyl y-Keto Imides

2-Iodomethyl-l-(2-oxo-oxazolidin-3-yl)-pentane-l, 4-dione 102
An oven-dried, one-necked, 100-mL round-bottomed flask equipped with a rubber
septum and magnetic stir-bar was cooled to room temperature under a nitrogen
atmosphere, and charged with l-(2-oxo-oxazolidin-3-yl)-butane-l,3-dione (0.346 g, 2.0
mmol) dissolved in 30 mL o f methylene chloride. The solvent was cooled to 0 °C in an
ice bath and diethyl zinc (10.0 mL, 1.0 M in hexane, 10.0 mmol) was added slowly to the
flask at 0 °C over two min to form an enolate. The reaction mixture was stirred for 15
min, and then methylene iodide (0.48 mL, 6.0 mmol) was added into the flask. An
additional portion o f methylene iodide (0.32 mL, 4.0 mmol) was added to the reaction
mixture at 0 °C after 15 to 20 min. The resulting solution was stirred for 30 min, and
trimethylsilylchloride (50 pL, 0.4 mmol) was added by micro-syringe in one portion. The
mixture was allowed to stir for 30 min at room temperature followed by the addition o f
iodine (2.58 g, 10.0 mmol) to the reaction mixture. The reaction mixture quickly became
a pink suspension and was stirred for 10 min, quenched with 10 mL o f saturated aqueous
ammonium chloride, and extracted with ether acetate (5x20 mL). The combined organic
layers were washed with saturated sodium thiosulfate solution (2x25 mL), and brine
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(3x25 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under
reduced pressure (25 °C, 20 torr). The residue was purified by column chromatography
on silica (2:1, hexane: ethyl acetate, R / -

0.16) to yield 0.101 g (31%) o f

2-iodomethyl-l-(2-oxo- oxazolidin-3-yl)-pentane-l,4-dione 102 as a yellow solid, mp
71-75 °C; !H NMR (400 MHz, CDC13) 5 4.50-4.42 (m, 2 H), 4.31 (m, 1 H), 4.12-3.97 (m,
2H), 3.39 (dd, J = 5.4, 10.2 Hz, 1H), 3.32 (dd, J = 6.5, 10.1 Hz, 1H), 3.16 (dd, J = 9.9,
18.1 Hz, 1H), 2.75 (dd, J = 4.1, 18.0 Hz, 1H), 2.18 (s, 3H); 13C NMR (100 MHz, CDCI3 )
5 206.1, 172.3, 153.4, 62.4, 46.6, 42.9, 39.0, 29.9, 4.4.

3-[l-Hydroxy-2-(2-oxo-propyl)-cyclopropyl]-oxazolidin-2-one 107 and 2-M ethyl-l(2-oxo-oxazolidin-3-yl)-pentane-l, 4-dione 108
An oven-dried, one-necked, 100-mL round-bottomed flask equipped with a rubber
septum and magnetic stir-bar was cooled to room temperature under a nitrogen
atmosphere, and charged with l-(2-oxo-oxazolidin-3-yl)-butane-l,3-dione (0.171 g, 1
mmol) dissolved in 15 mL o f methylene chloride. The solvent was cooled to 0 °C in an
ice bath and diethyl zinc (5.0 mL, 1.0 M in hexane, 5.0 mmol) was added slowly to the
flask at 0 °C over two min to form an enolate. The reaction mixture was stirred for 15
min, and then methylene iodide (0.24 mL, 3.0 mmol) was added into the flask. An
additional portion o f methylene iodide (0.16 mL, 2.0 mmol) was added to the reaction
mixture at 0 °C after 15 to 20 min. The resulting solution was stirred for 30 min, and
trimethylsilylchloride (50 pL, 0.4 mmol) was added by micro-syringe in one portion. The
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Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

mixture was allowed to stir for 45 min, quenched with 10 mL o f saturated aqueous
ammonium chloride, and extracted with ether acetate (3x20 mL). The combined organic
layers was washed with brine (3x15 mL), dried over anhydrous sodium sulfate, filtered,
and concentrated under reduced pressure (25 °C, 20 torr). The residue was purified by
column chromatography on silica (2:1, hexane: ethyl acetate, R / = 0.08) to yield 0.06 g
(30%)

of

3-[l-hydroxy-2-(2-oxo-propyl)-cyclopropyl]-oxazolidin-2-one

as

107

a

colorless liquid. ]H NMR (400 MHz, CDC13)

8

4.28-4.16 (m, 2 H), 3.76-3.66 (m, 2 H),

2.56 (dd, J = 4.1,17.4 Hz, 1 H ), 2.35 (dd,

8.8,18.2 Hz, 1 H), 2.09 (s, 3 H), 1.64-1.59

(m, 2 H), 1.18 (m, 1 H), 0.78 (t, J = 6.9 Hz, 1 H); 13C NMR (100 MHz, CDC13)

8

209.1,

158.2, 65.2, 62.8, 43.4, 42.3, 30.3, 20.9, 20.5; IR (neat, cm '1): 3442(b), 2927, 1775, 1699,
1390, 1227, 1039.
A compound 2-methyl-l-(2-oxo-oxazolidin-3-yl)-pentane-l, 4-dione 108 was also
isolated from the crude reaction mixture by column chromatography on silica (2 : 1 ,
hexane: ethyl acetate, R / = 0.16) in a 22% yield (0.043 g) as a colorless liquid. *H NMR
(400 MHz, CDC13)

8

4.43-4.30 (m, 2 H), 4.41-3.95 (m, 3 H), 3.10 (dd, J = 10.3, 18.1 Hz,

1 H), 2.53 (dd, J = 4.1, 18.2, 1 H), 2.14 (s, 3 H), 1.18 (d, J = 7.0 Hz, 3 H); 13C NMR (100
MHz, CDC13)

8

207.1, 176.8, 153.4, 62.2, 47.4, 42.9, 33.3, 29.8, 17.3. IR (neat, cm '1):

1775, 1698, 1392, 1264,1202.
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l-((.S)-4-Benzyl-2-oxo-oxazolidin-3-yl)-2-iodomethyl-pentane-l,

4-dione

113

and

(5)-4-Benzyl-3-[l-hydroxy-2-(2-oxo-propyI)-cyclopropyl]-oxazolidin-2-one 114
An oven-dried, one-necked, 50-mL round-bottomed flask equipped with a rubber
septum and magnetic stir-bar was cooled to room temperature under a nitrogen
atmosphere, and charged with a solution o f 1-((5) 4-benzyl-2-oxo-oxazolidin-3-yl)
-butane-1,3-dione 112 ( 0.261 g, 1.0 mmol) in 15 mL o f methylene chloride. The solvent
is cooled to 0 °C in an ice bath and diethyl zinc (5.0 mL, 1.0 M in hexane, 5.0 mmol) was
added slowly to the flask at 0 °C over two min to form an enolate. The reaction mixture
was stirred for 15 min, and then methylene iodide (0.24 mL, 3.0 mmol) was added into
the flask. An additional portion o f methylene iodide (0.16 mL, 2.0 mmol) was added to
the mixture at 0 °C after 15 to 20 min. The resultant solution was stirred for 30 min, and
trimethylsilylchloride (25 pL, 0.2 mmol) was added by micro-syringe in one portion. The
mixture was allowed to stir for 30 min at room temperature followed by adding iodine
(1.265 g, 5.0 mmol) to the reaction. The reaction mixture quickly became a pink
suspension and was stirred for 10 min, quenched with 10 mL o f saturated aqueous
ammonium chloride, and extracted with ether acetate (3x20 mL). The combined organic
layers were washed with saturated sodium thiosulfate solution (2x15 mL) and brine
(3x15 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under
reduced pressure. The residue was purified by column chromatography on silica (3:1,
hexane:

ethyl

acetate,

R/

=

0.28)

to

yield

0.11

g

(26%)

of

l-((5)-4-Benzyl-2-oxo-oxazolidin-3-yl)-2-iodomethyl -pentane-1,4-dione 113 as a light
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yellow liquid o f two diastereoisomers with a ratio o f 2.5:1. *H NMR (400 MHz, CDCI3 )

8

7.33-7.20 (m, 5 H), 4.80-4.67 (m, 1 H), 4.31-4.16 (m, 3 H), 3.42 (d, J = 5.5 Hz, 2 H),
3.36-3.33 (m, 1 H), 3.20 (dd, J = 10.1, 18.1 Hz, 1 H), 2.87-2.69 (m, 2 H), 2.19 (s, 3 H);
13C NMR (100 MHz, CDCI3 )

8

206.0, 172.0, 153.3, 140.9, 129.6, 129.2, 127.7,

6 6 .8

,

55.5, 46.4, 40.0, 38.5, 37.8, 29.9, 4.9; MS (MALDI): calcd for C i 6H i 8 0 4N I (M+-I)
288.2782: found, 287.7.
The compound l-((5)-4-Benzyl-2-oxo-oxazolidin-3-yl)-pent-2-ene-l,4-dione was
also present in the reaction mixture. Resonances observed for this compound: 'H NMR
(400 MHz, CDCI3 )
MHz, CDCI3 )

8

8

8.0 (d, J = 15.9 Hz, 1 H), 7.1 (d,

15.9 Hz, 1 H); 13C NMR (100

198.1, 164.4, 135.1, 27.8.

The crude reaction mixture was also purified by column chromatography on silica
(1:1, hexane: ethyl acetate, R /= 0.12) to produce 0.08 g (28%) o f one predominant
stereoisomer o f (5)-4-Benzyl-3-[l-hydroxy-2-(2-oxo-propyl)-cyclopropyl]-oxazolidin-2one 114 as a colorless crystal, mp 102-103 °C; [a ]25o = +4.8 (c = 0.0053 g/mL, CHCI3 ).
JH NMR (400 MHz, CDCI3 )

7.39-7.25 (m, 5 H), 4.75 (s, 1 H), 4.22 (m, 1 H), 4.07-3.98

8

(m, 2 H), 3.54 (d d ,J = 3 .8 , 13.4 Hz, 1H),2.83 ( d d ,J = 4 .5 ,18.4 Hz, 1 H), 2.71-2.62 (m, 2
H), 2.22 (s, 3 H), 1.54 (m, 1 H), 1.38 (dd, J - 5.9, 10.1 Hz, 1 H), 0.96 (t, J = 6.2 Hz, 1 H);
,3C NMR (100 MHz, CDCI3 )

8

208.5, 157.8, 136.7, 129.7, 129.2, 127.1, 66.9, 64.8, 57.6,

42.1, 38.4, 30.2, 21.8, 19.6. IR (KBr, cm '1): 3317 (b), 3029, 2921, 1745, 1603, 1413,
1246. MS (MALDI): calcd for C 16H i 9 0 4N (M+ +Na+) 312.1871: found, 312.1; calcd for
C ]6 H i 9 0 4N (M+ +K+) 328.3000: found, 328.1.
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6.

Preparation of a-Alkylated y-Keto Esters

2-Benzyl-5, 5-dimethyl-4-oxo-hexanoic acid methyl ester 115
A mixture o f zinc dust (0.09 g, 1.4 mmol) and iodine (2.0 mg, 0.005 mmol) was
placed into an oven-dried, 25-mL round-bottomed flask equipped with a rubber septum
and magnetic stir bar. The flask was allowed to cool to room temperature under nitrogen
gas. Dimethylformamide (1 mL) was added via syringe into the flask, followed by the
addition o f a solution o f iodobenzene (0.224 g, 1.1 mmol) in 4 mL o f DMF dropwise by
syringe. The reaction mixture was stirred at 0 °C (ice bath) for 30 min. The ice bath was
removed and the septum was replaced with a reflux condenser after 2-iodomethyl-5,
S-dimethyl-4-oxo-hexanoic

acid

methyl

ester

82

(0.312

tris(dibenzylideneaeetone)dipalladium(0) (45 mg, 0.05 mmol) and

g,

1.0

mmol),

tri-o-tolylphosphine

(60 mg, 0.2 mmol) were added. The reaction mixture was heated to 60 °C and stirred for
5 h. The resulting black mixture was decanted to an Erlenmeyer flask containing 10 mL
o f deionized water. An additional 5 mL o f saturated citric acid solution was added in
order to break the emulsion. The mixture was extracted with diethyl ether (3x10 mL), and
the combined organic layers were washed with deionized water (2x10 mL) and brine
(2x10 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under

reduced pressure. The residue was purified by column chromatography (30:1, hexane:
ethyl acetate, R/= 0.14) to yield 0.79 g (30%) o f 2-benzyl-5,5 -dimethyl-4-oxo-hexanoic
acid methyl ester 115 as a clear orange liquid. 'H NMR (400 MHz, CDCI3 ) 8 7.26 (t, J =
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7.4 Hz, 2 H), 7.19 (t, J = 7.3 Hz, 1 H), 7.13 (d, J =
1H), 2.99 (dd, J =

6 .6

6 .8

Hz, 2H), 3.61 (s, 3 H), 3.14 (m,

, 13.5 Hz, 1 H), 2.92 (dd, J = 9.0, 18.2 Hz, 1 H), 2.72 (dd, J = 8.3,

13.6 Hz, 1 H), 2.56 (dd, J = 4.6, 18.1 Hz, 1 H), 1.08 (s, 9 H); 13C NMR (100 MHz,
CDCI3 )

6

214.3, 175.6, 138.8, 129.4, 129.1, 126.8, 51.9, 44.1, 42.2, 37.9, 26.6; IR (neat,

cm '1): 2966, 1736, 1704, 1476, 1366, 1230; MS (ESI): calcd for C 16H 22 O 3 (M+ +Na+)
285.1919: found, 285.1.

2-(4-Chloro-benzyl)-5, 5-dimethyl-4-oxo-hexanoic acid methyl ester 116
A mixture o f zinc dust (0.09 g, 1.4mmol) and iodine (2.0 mg, 0.005 mmol) was
placed into an oven-dried, 25-mL round-bottomed flask equipped with a rubber septum
and magnetic stir bar. The flask was allowed to cool to room temperature under nitrogen
gas. Dimethylformamide (1 mL) was added via syringe into the flask followed by
dropwise addition o f a solution o f 1-chloro-4-iodobenzene (0.3.0 g, 1.26 mmol) in 4 mL
o f DMF. The reaction mixture was stirred at 0 °C (ice bath) for 30 min. The ice bath was
removed and the septum was replaced with a reflux condenser after 2-iodomethyl-5,
5-dimethyl-4-oxo-hexanoic

acid

methyl

tris(dibenzylideneacetone)dipalladium(0)

ester
(45.0

82
mg,

(0.312
0.05

g,

1.0
mmol)

mmol),
and

tri-o-tolylphosphine (60 mg, 0.2 mmol) were added. The reaction mixture was heated to
60 °C and stirred for 5 h. The resulting black mixture was decanted to an Erlenmeyer
flask containing 10 mL o f deionized water. An additional 5 mL o f saturated citric acid
solution was added in order to break the emulsion. The mixture was extracted with
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diethyl ether (3x10 mL), and the combined organic layers were washed with deionized
water (2x10 mL) and brine (2x10 mL), dried over anhydrous sodium sulfate, filtered, and
concentrated

under

reduced

pressure.

The

residue

was

purified

by

column

chromatography (20:1, hexane: ethyl acetate, R /= 0.18) to yield 0.075 g (25%) o f
2-(4-chloro-benzyl)-5,5 -dimethyl- 4-oxo-hexanoic acid methyl ester 116 as a clear
orange liquid. 'H NMR (400 MHz, CDC13)

.8

7.25 (d, J =

8 .6

Hz, 2 H), 7.09 (d, J = 8.3

Hz, 2 H), 3.62 (s, 3 H), 3.15 (m, 1 H), 2.96 (dd, J = 7.0, 11.9 Hz, 1 H), 2.92 (dd, J = 8.5,
18.0 Hz, 1 H), 2.71 (dd,

7.8, 13.8 Hz, 1 H), 2.54 (dd, J = 4 .9 , 18.1 Hz, 1 H), 1.09 (s, 9

H); 13C NMR (100 MHz, CDC13)

8

214.0, 175.6, 137.3, 132.6, 130.5, 128.8, 52.1, 44.3,

42.2, 38.5, 36.6, 26.6; IR (neat, cm '1): 2967, 1736, 1704, 1492, 1169.

fer#-Butyl-(4-iodo-phenoxyl)-dimethyl-silane 117
Into an oven-dried, 50-mL round-bottomed flask purged under N 2 and equipped
with a rubber septum and magnetic stir bar were placed iodophenol (1.1 g, 5.0 mmol),
t-butyldimethylsilyl chloride (1.2 g, 7.5 mmol) and 12 mL o f pyridine. The reaction
mixture was heated to 45 °C (water bath) and stirred for 4 h. The resultant solution was
extracted by diethyl ether (3x15 mL) and neutralized by IN HC1 solution (2x10 mL),
then washed with brine (3X20 mL), dried over anhydrous sodium sulfate, filtered, and
concentrated under reduced pressure. The crude residue was purified by column
chromatography using pure ether acetate as the mobile phase (R/ = 0.8) to yield 0.73 g
(44%) o f tert-butyl-(4-iodo-phenoxyl)-dimethyl-silane as a colorless liquid. 'H NMR
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(400 MHz, CDCI3 )
0.07 (s,

6

8

7.32 (d, J =

8 .6

Hz, 2 H), 6.42 (d, J =

H); 13C NMR (100 MHz, CDCI3 )

8

8 .6

Hz, 2 H); 0.86 (s, 9 H),

160.1, 142.75, 126.9, 88.1, 30.1, 22.7, 0.0.

Acetic acid 4-iodo-phenyl ester 118
Into an oven-dried, 50-mL round-bottomed flask purged under N 2 and equipped with
a rubber septum and magnetic stir bar were placed iodophenol (1.1 g, 5.0 mmol), acetic
anhydride (0.7 mL, 7.5 mmol) and 10 mL o f pyridine. The reaction mixture was allowed
to stir at room temperature for 12 h. The resultant solution was extracted by diethyl ether
(3x20 mL). The combined ether layers were washed with brine (3x15 mL) and
neutralized by IN HC1 solution (2x10 mL), then washed with brine (2x15 mL) again,
dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure.
The crude residue was purified by column chromatography (20:1, hexane: ethyl acetate,
R/ = 0.25) to yield 1.14 g (87%) o f acetic acid 4-iodo-phenyl ester as a white solid. Mp
36-38 °C; *H NMR (400 MHz, CDC13)

8

7.68 (d, J = 8.7 Hz, 2 H),

H), 2.28 (s, 3 H); 13C NMR (100 MHz, CDC13)

8

6 .8 6

(d, J = 8.7 Hz, 2

169.2, 150.7, 138.8, 124.0, 90.1, 21.3;

IR (KBr, cm '1): 3083, 2264, 1980, 1758, 1577, 1479, 1368.

2-Benzyl-l-(2-oxo-oxazolidin-3-yl)-pentane-l, 4-dione 121
A mixture o f zinc dust (0.09 g, 1.4 mmol) and iodine (2.0 mg, 0.005 mmol) was
placed into an oven-dried, 25-mL round-bottomed flask equipped with a rubber septum
and magnetic stir bar. The flask was allowed to cool to room temperature under nitrogen
gas. Dimethylformamide (1 mL) was added via syringe into the flask followed by the
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dropwise addition o f a solution o f iodobenzene (0.224 g, 1.1 mmol) in 4 mL o f DMF.
The reaction mixture was stirred at 0 °C (ice bath) for 30 min. The ice bath was removed
and the septum

was replaced with a reflux

(2-oxo-oxazolidin-3-yl)-pentane-l,

4-dione

102

condenser after
(0.325

2

-iodomethyl-l-

g,

1.0

mmol),

tris(dibenzylideneacetone)dipalladium(0) (45 mg, 0.05 mmol) and tri-o-tolyl phosphine
(60 mg, 0.2 mmol) were added. The reaction mixture was heated to 60 °C and stirred for
5 h. The resulting black mixture was decanted to an Erlenmeyer flask containing 10 mL
o f deionized water. An additional 5 mL o f saturated citric acid solution was added in
order to break the emulsion. The mixture was extracted with ether acetate (3x10 mL), and
the combined organic layers were washed with deionized water (2x10 mL) and brine
(2x10 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under
reduced pressure. The residue was purified by column chromatography (1:1, hexane:
ethyl acetate, R / = 0.47) to yield 0.066 g (24%) o f 2-benzyl-l-(2-oxo-oxazolidin
-3-yl)-pentane- 1,4-dione 121 as a white solid, mp 108-111 °C; VH NMR (400 MHz,
CDC13)

6

7.30-7.27 (m, 5 H), 4.45-4.30 (m, 3 H); 4.05 (dd, 7 = 6.7, 9.4 Hz, 1 H), 3.93

(dd, J = 6.9, 9.3 Hz, 1 H), 3.09 (dd, 7 = 5.1, 13.1 Hz, 1 H), 3.03 (dd, 7 = 10.7, 18.0 Hz, 1
H), 2.51 (dd, 7 = 10.0, 13.1 Hz, 1 H), 2.45 (dd, 7 = 3.5, 18.3 Hz, 1 H), 2.07 (s, 3 H); I3C
NMR (100 MHz, CDCI3 )

6

207.2, 175.7, 153.4, 138.2, 129.4, 128.7, 126.9, 62.2, 44.4,

42.9, 40.2, 37.9, 29.9. IR (KBr, cm '1): 2921, 1773, 1715, 1480, 1395, 1263.

73

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

5 . 5-Dimethyl-2-(2-methyl-allyl)-4-oxo-hexanoic acid methyl ester 122
A mixture o f zinc dust (0.09 g, 1.4 mmol) and iodine (2.0 mg, 0.005 mmol) was
placed into an oven-dried, 25-mL round-bottomed flask equipped with a rubber septum
and magnetic stir bar. The flask was allowed to cool to room temperature under nitrogen
gas. Dimethylformamide (1 mL) was added via syringe into the flask followed by the
dropwise addition o f a solution o f 2-bromo-l-propene (0.30 g, 1.26 mmol) in 4 mL o f
DMF. The reaction mixture was stirred at 0 °C (ice bath) for 30 min. The ice bath was
removed and the septum was replaced with a reflux condenser after 2-iodomethyl-5,
5-dimethyl-4-oxo-hexanoic

acid

methyl

ester

82

(0.312

g,

tris(dibenzylideneacetone)dipalladium(0) (45 mg, 0.05 mmol) and

1.0

mmol),

tri-o-tolylphosphine

(60 mg, 0.2 mmol) were added. The reaction mixture was heated to 60 °C and stirred for
5 h. The resulting black mixture was decanted to a Erlenmeyer flask containing 10 mL o f
deionized water. An additional 5 mL o f saturated citric acid solution was added in order
to break the emulsion. The mixture was extracted with diethyl ether (3x10 mL), and the
combined organic layers were washed with deionized water (2x10 mL) and brine (2x10
mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced
pressure. The residue was purified by column chromatography (20:1, hexane: ethyl
acetate,

R/

=

0.15)

to

yield

0.075

g

(12%)

of

5.5-dimethyl-2-(2-methyl-allyl)-4-oxo-hexanoic acid methyl ester 122 as a clear orange
liquid. *H NMR (400 MHz, CDC13) 5 4.79 (s, 1 H), 4.69 (s, 1 H), 3.66 (s, 3 H), 3.07 (m, 1
H), 2.92 (dd, J = 9.3, 18.1 Hz, 1 H), 2.58 (dd, J = 4.2, 18.1 Hz, 1 H), 2.38 (dd, J =
74
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6 .8

,

14.2 Hz, 1 H), 2.14 (dd, 7 = 8.5, 14.6 Hz, 1 H), 1.79 (s, 3 H), 1.14 (s, 9 H); 13C NMR
(100 MHz, CDC13) 8 214.4,175.9,142.8, 113.2,51.9,44.2,40.5,38.4,38.1,26.5,21.9.

7.

Preparation of Compound 124

(5)-2-(4-Methoxy-benzylamino)-3-methyl-butyric acid 126
To a 250-mL round-bottomed flask containing a solution o f L-valine (12.42 g, 106
mmol) in 50 mL o f 2.0 M NaOH was added p-anisaldehyde (12.7 mL, 104.0 mmol) in
one portion. The reaction mixture was allowed to stir at room temperature for 30 min,
cooled to 0 °C and sodium borohydride (1.6 g, 42.0 mmol) was added in small portion.
After an additional 30 min, a second portion o f />anisaldehyde ( 6 . 8 mL, 56.0 mmol) was
added into the mixture and kept stirring for

1

h, then a second portion o f sodium

borohydride (1.6 g, 42.0 mmol) was added and after 4 h the mixture was neutralized with
1 N HC1 to PH 6 . The resulting white precipitate was collected by filtration, washed with
cold water and air-dried for 2 h. The solid was dissolved in 100 mL o f 1 M NaOH and
extracted with diethyl ether (2^50 mL). The aqueous layer was neutralized with 1 N HC1
to PH

6

. The resulting white solid was collected by filtration and dried under reduced

pressure to yield 14.6 g (58%) o f (5)-2-(4-methoxy-benzylamino)- 3-methyl-butyric acid
126 as a white powder, mp 244-247 °C; !H NMR (400 MHz, DMSO-d 6 /TFA)
=

8 .8

Hz, 2 H), 7.00 (d, J =

8 .8

8

7.42 (d, J

Hz, 2 H), 4.12 (s, 2 H), 3.78 (s, 3 H), 3.72 (s, 1 H),

2.32-2.27 (m, 1 H), 1.03 (d, J = 7.0 Hz, 3 H), 0.94 (d, J = 6.9 Hz, 3 H); 13C NMR (100
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MHz, DMSO-d6/TFA) 8 169.7, 159.6, 132.7, 123.5, 117.5, 64.3, 54.9, 50.4, 29.1, 18.9,
18.8;IR (K B r, cm '1): 3447(b), 2962, 1602, 1515, 1454, 1322, 1254, 1221, 1177.

(iS )-2 - [Benzyloxycarbonyl-(4-methoxy-benzyl)-amiiio] -3-methyl-butyric acid 127
Pmb-protected L-valine 126 (1.19 g, 5.0 mmol) was dissolved in the 20 mL o f 1 N
NaOH and 20 mL o f THF. The mixture was kept stirring at room temperature for 30 min,
then cooled to 0 °C and benzyloxycarbonyl chloride (0.69 mL, 5.0 mmol) was added in
one portion. The reaction was vigorously stirred overnight. The resulting mixture was
washed with ether (2x15 mL) and acidified with conc. HC1 to pH 1. The resulting cloudy
solution was extracted with ethyl acetate (3x20 mL). The combined organic layers were
washed with brine (2x15 mL), dried over anhydrous sodium sulfate, filtered, and
concentrated under reduced pressure to yield 0.93 g (50%) o f compound 127 as a light
yellow oily liquid. The compound exists as a mixture o f 2 rotameric forms . 1H NMR (400
MHz, CDC13)

8

10.0 (bs, 1 H), 7.37-6.77 (m, 9 H), 5.17 (s, 2 H), 4.53-4.44 (m, 2 H), 3.99

(m, 1 H), 3.72 (s, 3 H), 2.42-2.26 (m, 1 H), 1.01-0.68 (m,
CDCI3 )

8

6

H); 13C NMR (100 MHz,

176.2, 174.6, 159.1, 157.7, 136.4, 130.4, 130.1, 129.4, 128.7, 128.5, 128.4,

128.2, 113.9, 68.3, 68.1, 65.4, 55.4, 50.8, 27.9, 20.4, 19.6; IR (neat, cm '1): 3500-2837 (b),
2964, 1736, 1700, 1613, 1513, 1458, 1247.
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[4-((/?)-4-Benzyl-2-oxo-oxazolidin-3-yl)-(S)-l-isopropyl-2,
4-dioxo-butyl]-(4-methoxy-benzyI)-carbamic acid benzyl ester 129
An oven-dried, 10-mL round-bottomed flask equipped with a rubber septum and
magnetic stir-bar was purged under nitrogen, and charged with 4 mL o f anhydrous
tetrahydrofuran, compound 127 ( 0.381 g, 1.0 mmol, in 1 mL o f anhydrous THF), and
1,1-carbonyldiimidazole (0.18 g, 1.1 mmol) in order. In a separate oven-dried, 50-mL
round-bottomed flask, equipped with a rubber septum and magnetic stir-bar under
nitrogen, were charged with 15 mL o f anhydrous tetrahydrofuran and diisopropylamine
(0.57 mL, 4.0 mmol). The solution was allowed to cool to 0 °C (ice bath) and «-butyl
lithium (1.9 mL, 4.0 mmol, 2.1 M in hexane solution) was added. After stirring for 10
min, the reaction mixture was cooled to -78 °C (dry ice in acetone bath),
(/?)-3-acetyl-5-benzyl oxazolidin-2-one (0.88 g, 4.0 mmol, in 5 mL o f anhydrous THF)
was added over 30 min using a syringe pump. The acyl imidazole solution was
transferred to the 50-mL flask containing the enolate solution using syringe quickly. The
reaction was quenched with 5 mL o f IN HC1 solution after stirring at -78 °C for 30 min.
The solution was extracted with diethyl ether (3x10 mL), and the combine ether layers
were washed with 10 mL o f sat.NaHCC >3 solution to remove the acid. The organic layer
was washed with 5 mL o f brine, dried over anhydrous sodium sulfate, filtered, and
concentrated

under

reduced

pressure.

The

residue

was

purified

by

column

chromatography (3:1, hexane: ethyl acetate, R / = 0.28) to yield 0.337 g (59%) o f
compound 129 as a light yellow oily mixture. [a]25o = -85.0 (c = 0.006 g/mL, CHCI3 ); *H
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NMR (400 MHz, CDC13) 5 7.32-7.03 (m, 12 H), 6.79-6.69 (m, 2 H), 5.17-5.04 (m, 2 H),
4.73-4.49 (m, 2 H), 4.18-4.00 (m, 4 H), 3.89-3.60 (m, 1 H), 3.70-3.69 (m, 3 H), 3.29-3.20
(m, 1 H), 2.72-2.63 (m, 1 H), 2.38-2.23 (m, 1 H), 0.93-0.80 (m, 3H), 0.72-0.64 (m, 3 H);
13C NMR (100 MHz, CDCI3 )

6

200.2, 166.8, 159.5, 156.5, 153.5, 136.4, 135.5, 131.1,

130.4, 129.7, 129.2, 128.8, 128.4, 127.5, 114.1, 71.1, 68.1, 66.4, 55.5, 55.2, 49.9, 49.1,
48.6, 37.5, 27.3, 26.7, 21.6, 20.8, 19.1; IR (neat, cm '1): 3029, 2962, 1779, 1697, 1611,
1512, 1454, 1359, 1247; MS (ESI): calcd for C 33 H 36 O 7N 2 (M+ +Na+) 596.3569: found,
595.1.

[5-((/?)-4-Benzyl-2-oxo-oxazolidin-3-yl)-4-iodomethyl-(5)-l-isopropyl-2,
5-dioxo-pentyl]-(4-methoxy-benzyl)-carbamic acid benzyl ester 130
An oven-dried, one-necked, 100-mL round-bottomed flask equipped with a rubber
septum and magnetic stir-bar with a flow o f nitrogen was cooled to room temperature,
and charged with compound 129 ( 0.26 g, 0.45 mmol) dissolved in

8

mL o f methylene

chloride. The solvent was cooled to 0 °C in an ice bath and diethyl zinc (2.3 mL, 1.0 M in
hexane, 2.3 mmol) was added slowly to the flask at 0 °C over 1 min to form an enolate.
The reaction mixture was stirred for 15 min, and then methylene iodide (0.11 mL, 1.38
mmol) was added into the flask. An additional portion o f methylene iodide (0.07 mL,
0.87 mmol) was added to the reaction mixture at 0 °C after 30 min. The resulting solution
was stirred for 30 min, and trimethylsilylchloride (12.5 pL, 0.2 mmol) was added by
micro-syringe in one portion. The mixture was allowed to stir for 1 h at 0 °C followed by
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the addition o f iodine (0.57 g, 2.25 mmol) to the reaction. The reaction mixture quickly
became a pink suspension and stirred for 10 min, quenched with 5 mL o f saturated
aqueous ammonium chloride, and extracted with ether acetate (3x15 mL). The combined
organic layers were washed with saturated sodium thiosulfate solution (2x10 mL), and
brine (3x15 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under
reduced pressure. The residue was purified by column chromatography on silica (5:1,
hexane: ethyl acetate, R / = 0.27) to yield 0.15 g (46%) o f compound 130 as a orange oily
liquid. *H NMR (400 MHz, CDC13)

8

7.49-7.06 (m, 12 H), 6.86-6.76 (m, 25.5 Hz, 2 H),

5.27-5.20 (m, 2 H), 4.70-4.59 (m, 1 H), 4.51-4.40 (m, 1 H), 4.28-4.11 (m, 4 H), 4.04-3.86
(m, 1 H), 3.80 (s, 3 H), 3.34-3.25 (m, 1 H), 3.17-3.02 (m, 2 H), 2.89-2.69 (m, 2 H),
2.60-2.33 (m, 2 H), 1.00-0.73 (m,

6

H); 13C NMR (100 MHz, CDC13)

8

205.4, 171.8,

159.4, 155.6, 153.8, 136.4, 135.4, 130.8, 129.9, 129.7, 129.3, 129.1, 128.8, 128.4, 127.6,
114.2, 69.3, 68.5, 66.5, 60.6, 58.1, 55.4, 48.2, 43.8, 38.4, 30.2, 26.2, 21.5, 19.6, 4.7; MS
(ESI): calcd for C 35 H 39 O 7 N21 (M+ +Na+) 749.5965: found, 749.1.

8.

Preparation of a-Methylthiolated y-Keto Esters

2-(2-Methoxycarbonyl-5,
5-dimethyl-4-oxo-hexylsulfanylmethyl)-5,5-dimethyl-4-oxo-hexanoid

acid

methyl

ester 140
Into an oven-dried, one-necked, 25-mL round-bottomed flask equipped with a
rubber septum and magnetic stir-bar with a flow o f nitrogen were placed sodium sulfide
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Na 2 S (0.78 g, 10.0 mmol) and 9 mL o f N, A^-dimethylform amide. The solution was for 20
min at room temperature. The yellow suspension was allowed to cooled in a -15 °C ( dry
ice in ethylene glycol) and compound 82 (0.312 g, 1.0 mmol, in 1 mL o f DMF) was
added to the reaction mixture which was stirred for 5 h. The reaction was quenched with
2 mL o f sat. NH 4 CI solution. The DMF and water were removed under reduced pressure
(50 °C, 18 torr). The residue was extracted with diethyl ether (3x15 mL) and the
combined organic layers were washed with brine (3x15 mL), dried over anhydrous
sodium sulfate, filtered, and concentrated under reduced pressure. The residue was
purified by column chromatography on silica (6:1, hexane: ethyl acetate, R / = 0.09) to
yield 0.09 g (25%) o f compound 140 as a light yellow liquid. 'H NMR (400 MHz,
CDCI3) 5 3.67 (s,

6

H), 3.11-3.04 (m, 2 H), 3.02-2.98 (m, 2 H), 2.85-2.75 (m, 4 H),

2.67-2.61 (m, 2 H), 1.13 (s, 18 H); 13C NMR (100 MHz, CDCI3)

8

213.8, 174.3, 52.2,

44.2, 42.4, 37.7, 34.0, 26.6; IR (neat, cm '1): 2967, 1737, 1703, 1476, 1366, 1202. MS
(MALDI): calcd for C 2 oH34 0 6S (M+ +Na+) 425.6160: found, 425.6.

2-Acetylsulfanylmethyl-5, 5-dimethyl-4-oxo-hexanoid acid methyl ester 142
Into an oven-dried, one-necked, 10-mL round-bottomed flask equipped with a rubber
septum and magnetic stir-bar with a flow o f nitrogen were placed potassium thioacetate
(0.23 g, 2.0 mmol), compound 82 (0.312 g, in 1 mL o f tetrahydrofuran, 1.0 mmol) and
4.0 mL o f tetrahydrofuran. The light yellow suspension was allowed to stir overnight at
room temperature. The resultant brown suspension was extracted with diethyl ether (3x15
80
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mL) and the organic layer was removed using a pipette. The combined ether extracts
were washed with brine (3x15 mL), dried over anhydrous sodium sulfate, filtered, and
concentrated

under

reduced

pressure.

The

residue

was

purified

by

column

chromatography on silica (15:1, hexane: ethyl acetate, R / = 0 .1 0 ) to yield 0.17 g (65%)
o f 2-acetylsulfanylmethyl-5,5-dimethyl-4-oxo-hexanoid acid methyl ester 142 as a
orange liquid. ’H NMR (400 MHz, CDC13) 5 3.63 (s, 3 H), 3.16 (dd, J = 8.0, 15.6 Hz, 1
H), 3.08-3.02 (m, 2 H), 2.96 (dd, J = 7.2, 18.0 Hz, 1 H), 2.64 (dd, J = 4.2, 17.8 Hz, 1 H),
2.27 (s, 3 H), 1.08 (s, 9 H); 13C NMR (100 MHz, CDC13)

8

213.8, 194.9, 173.8, 52.3,

44.1, 40.3, 37.5, 30.5, 30.2, 26.6.
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